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PREFACE 
Every single cell in the human body is built by nutrients. Nutrients are also the sole source of 
the energy needed to ensure life and movement.  All the nutrients we need, both - micro- and 
macronutrients, are present in the food we consume. It is therefore logical that malnutrition 
will affect health in one way or another. The importance of an understanding of the 
relationship between food and health is by no means new. The famous ancient Greek 
physician Hippocrates (460-377 BC) argued that disease was a result of environmental
factors such as diet and living habits, rather than punishment from the gods as was a 
common belief at the time. Today, the efficient marketing and overwhelming distribution and 
availability of energy dense food, combined with a built environment which does not 
encourage physical activity, has resulted in an obesogenic environment. At present, obesity 
(body mass index (BMI) 30 kg/m2) affects more than 500 million people globally and has 
thereby become one of the major medical concerns of our century.  
At the turn of the millennium, and probably for the first time in history, the number of 
overweight people equalled the number of undernourished worldwide. Usually malnutrition 
has been associated with hunger and underfeeding. However, malnutrition is not only caused 
by energy deficiency, but by poor dietary quality. Diets containing excess saturated fat, 
added sugar and red meat, or lacking healthy foods and nutrients such as fruit and 
vegetables, whole grains and fibre may cause severe morbidity. Even though the causation 
is complex, obesity is a result of excess of energy intake compared to energy expenditure 
over a long period of time. One would think that excess energy would ensure enough 
essential nutrients, but this is not always the case. Obesity caused by the combination of 
excess energy and poor dietary quality may be considered a relatively new form of 
malnutrition.  
One of the best known examples of malnutrition in obesity is vitamin D deficiency. Vitamin D 
deficiency is associated with a variety of the same diseases also known to be prevalent 
among obese subjects; coronary heart disease (CHD), type 2-diabetes and different cancer 
forms.  In addition, obesity negatively affects the social life and psychological well-being of 
obese subjects and is associated with impaired quality of life. Both severe obesity and poor 
quality diet represent significant health risks, and the combination of the two risk factors is 
especially unfavourable.   
As the burden of obesity includes several diseases, which in themselves impose substantial 
medical costs and productivity losses, obesity treatment has been prioritised by several 
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governments and health authorities in high, middle, and low-income countries. Even though 
lifestyle intervention (diet and physical activity) is fundamental to the treatment of severe 
obesity, bariatric surgery has become widely used during the last few decades and has 
proven to be the most efficient method in terms of both weight reduction and sustained 
weight loss. Although total weight reduction is greater after bariatric surgery, due mainly to a 
more pronounced reduction in energy intake, little is known about how this treatment method 
affects the intake of nutrients, subsequent food group intake and therewith dietary quality.  
The aims of this thesis were to assess and compare changes in intake of specified food 
groups, energy yielding nutrients and vitamin concentrations in severely obese individuals 
undergoing either gastric bypass surgery or intensive lifestyle intervention during a 1-year 
non-randomised clinical intervention trial. Additionally the prevalence of vitamin D deficiency 
in a large cohort of morbidly obese Norwegian patients, as well as seasonal and gender 
based differences were explored. 
As such, the thesis hopes to expand the current understanding of how the most recognized 
treatment methods; lifestyle intervention and gastric bypass surgery; affect the intake of 
nutrients and certain food groups. It is also hoped that the results presented here contribute 
to highlighting the importance of dietary counselling in the treatment of morbid obesity in 
clinical practice.

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1 INTRODUCTION 
1.1 Definition of obesity 
The World Health Organization (WHO) defines overweight and obesity as abnormal or 
excessive fat accumulation that presents a risk to health (1). Total body fat includes essential 
body fat necessary for maintaining life, hormone production and reproductive function and 
storage fat accumulation ensuring protection of internal organs, isolation and energy reserve. 
Although there is no consensus as to the percentage of body fat needed to define obesity or 
excess percentage of body fat (2), 25% and 35% of body fat have been suggested as cut off 
levels for men and women, respectively (3). The percentage of body fat can be determined 
by a number of methods; the air displacement plethysmography method has been shown to 
be accurate and strongly correlate with the “gold standard” body fat measurement 
hydrodensiometry (underwater weighing) (4). Dual-energy X-ray absorptiometry (DEXA) is 
also considered a valid method for measuring total fat mass and fat distribution (5). However, 
this method exposes patients to radiation and the equipment is not always suitable (not 
spacious enough) for usage with severely obese individuals. Although bioelectric impedance 
analysis provides 2-6% lower values for fat mass than DEXA (6), the method is widely used 
given that it is inexpensive and easy to administer. Furthermore, body fat distribution can be 
determined by imaging techniques such as computed tomography (CT) and magnetic 
resonance imaging (MRI) (7;8). Accurate anthropometric measurements of height and weight 
are, however, the most common measurements used to determine the degree of obesity. 
Obesity defined as excess bodyweight is measured by body mass index [BMI=weight in 
kg/(height in m)2] and classified as shown in Table 1 (9). There is a strong correlation 
between BMI and fat mass, and cutoffs of percentage of body fat that correspond to BMI 
cutoffs have recently been suggested (10). The BMI classification of obesity does not, 
however, take body fat distribution into consideration. The accumulation of intra-abdominal 
fat increases the risk of developing metabolic obesity-related co-morbidities (coronary heart 
disease and diabetes type 2) (11;12). Waist circumference (WC) is an easily performed 
measurement which has been shown to correlate strongly with the degree of intra-abdominal 
fat accumulation (5). Independent of BMI, WC predicts the prevalence of coronary heart 
disease in both men and women (13;14). WC is considered an even more reliable measure
than waist-to-hip ratio (WHR) (5) for determining the degree of central fat mass. As fat-
distribution differs between men, women, and population-groups, cut-off levels for WC are 
sex- and ethnicity-specific (12). WC cut off-levels for indicating an increased risk of 
developing metabolic obesity-related co-morbidity are currently being debated within the 
field. A WC threshold for abdominal obesity in Caucasian women/men of 80 cm/ 94 cm 

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(moderately increased risk of type 2 diabetes and cardiovascular disease (CVD) or 88 cm / 
102 cm (highly increased risk of type 2 diabetes and CVD) are both being used today (12). 
Table 1. Classification of obesity according to the WHO’s definition (9). 
Classification BMI (kg/m2) Risk of morbidity 
Underweight <18,5 Low 
Normal weight 18.5-24.9 Average 
Overweight  25  
   Pre-obese 25.0-29.9 Increased 
   Obese, class I 30.0-34.9 Moderate 
   Obese, class II¹ 35.0-39.9 Severe 
   Obese, class III²  40 Very severe 
¹Morbid obesity when combined with at least one obesity-related co-morbidity 
 ²Morbid obesity 
 
1.2 Body weight regulation and energy balance 
Obesity develops as a result of the energy intake provided by food exceeding the energy 
expended to maintain metabolic, muscular and digestive activities (15). Although both daily 
energy intake and expenditure vary widely for most humans, body weight remains rather 
stable. Evidence indicates that both over- and underfeeding produce compensatory changes 
in energy expenditure in humans (16;17). However, human biology provides more effective 
mechanisms for protecting against underfeeding than overfeeding; humans are thus afforded 
better protection from weight loss than weight gain (15). Research in the last few decades 
has improved our understanding of the complex biological regulation of energy balance, and 
moreover how behavioural and environmental factors affect body weight regulation. This 
understanding is crucial if we are to develop strategies to halt the current obesity epidemic 
and treat those already affected.  
1.2.1  The energy homeostasis  
Complex hormonal and neural interplays regulate the energy homeostasis of humans, with 
the brain as the key regulator of appetite. Energy homeostasis is controlled by peripheral 
signals from adipose tissue, endocrine glands and enteroendocrine cells (18). Peripheral 
signals from the gastrointestinal tract include peptide YY (PYY), oxyntomodulin (OXM), 
ghrelin, pancreatic polypeptide (PP), glucagon-like peptide 1 (GLP-1) and cholecystokinin 
(CCK), whereas adiponectin and leptin are hormones produced in adipose tissue and insulin 
and PP in the pancreas. Hormones secreted from these tissues converge at the vagus 

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nerve, the brainstem and the hypothalamus to form complex interactions of neurotransmitters 
and central appetite-regulating peptides (18;19). The hypothalamus arcuate nucleus contains 
opposing sets of neuronal circuitry, both appetite-stimulating (+) and appetite-inhibiting (-) 
(Figure 1) (19;20). Two of them are the orexigenic neuropeptide Y/agouti-related peptide 
neurons and anorexigenic pro-opiomelanocortin/cocaine- and amphetamine-regulated 
transcript containing neurons (21).    
Moreover, the homeostatic control of food intake is strongly influenced by hedonism and the 
impact of taste and appearance, emotions, environment and social cues. These non-
homeostatic factors are processed in the cortico-limbic structures of the brain and seem to 
overpower the hypothalamus into an ingestive mode even in the presence of satiety (22).  
Although palatability and pleasantness are recognised as powerful determinants of food 
intake, the understanding of how the predicted reward value of pleasurable taste guides 
ingestive behaviour is currently inadequate (22).   
Obesogenic environments are characterised by an abundance of palatable and energy 
dense food (sugar- and fat-rich) easily available with low physical effort and cost. It has 
become evident that in competition with this milieu, the gut satiety signals are unable to limit 
excess energy intake (21). In fact, increasing evidence indicates that the gastrointestinal 
hormone secretion can adapt to a chronic increase in dietary fat, resulting in an attenuation 
of the natural suppression of appetite induced by fat-ingestion (23).  
Although the complex regulation of energy homeostasis is not the main theme of this thesis, 
it is important that one is aware of the major challenges associated with obesity treatment, in 
that biological and behavioural factors interact to oppose energy deficits.  

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Figure 1. Hormonal regulation of food intake (19). (Permission for use of the figure is not 
required). 
 
 
1.2.2 Components of energy balance 
The first law of thermodynamics states that the energy (E) of an isolated system is constant. 
This means that energy cannot be created from nothing nor can it disappear; it can only be 
transformed to other forms. Human physiology also follows this law. Eating and drinking 
provide all the energy needed for energy expenditure (EE) in humans.   
Total daily energy expenditure (TEE) can be divided into three main components and 
includes resting energy expenditure (REE) (synonymous with resting metabolic rate (RMR)), 
thermogenesis induced by food intake (diet-induced thermogenesis (DIT)) and the energy 
expenditure of physical activity (PAEE) (24). Basal energy expenditure (BEE) is synonymous 
with basal metabolic rate (BMR), and is defined as the energy expended by an individual 
lying at complete rest, about 12 hours after their previous meal (24;25). REE is measured in 
less rigorous conditions than BEE; in subjects at complete rest and in a post-absorptive 
state. REE is considered to be 5-10% higher than BEE. REE and BEE are, however, very 
strongly inter-correlated and are often used interchangeably (24).  
REE accounts for 50-70% of TEE. For persons in energy balance, DIT is assumed to be 
approximately 10% of TEE, whereas physical activity energy expenditure is estimated to be 
20-40% of TEE, and even higher for athletes (Figure 2) (26). TEE is strongly related to body 
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mass, and particularly fat free body mass (the weight of metabolically active tissue such as 
muscles, internal organs and bone), which explains approximately 80 % of the variance (27).   
Physical activity consists of a series of movements performed by the skeletal musculature, 
which in turn leads to an increase in energy expenditure. Exercise itself can be defined as 
planned, structured and repetitive physical activity which aims to either maintain or improve 
one’s physical fitness or health. All other physical activity, whether performed at work or 
during leisure time, can be defined as non-exercise activity or everyday activity (28).  
Physical activity can thus be divided into two main subcategories; planned exercise and non-
exercise activity. Non-exercise activity thermogenesis (NEAT) is the energy expended for all 
activities except sleeping, eating or planned exercise. NEAT includes energy expended on 
daily activities such as sitting, standing, walking, talking, gardening and all non-volitional 
muscle activities such as fidgeting, muscle tone and maintenance of posture (26). This non-
exercise activity has been suggested to be related to weight control given that obese 
individuals spend on average 2 hours more per day seated than their lean counterparts, who 
rather spend this time standing or ambulating (29). This difference in NEAT-behaviour 
accounts for the expenditure of approximately 350 kcal /day (29). Metabolic equivalent of 
task (MET) is the unit used to estimate the metabolic cost (i.e. oxygen consumption) of all 
physical activity. The MET depends on the intensity of the activity performed. One MET 
equals the resting metabolic rate of 3.5 ml O2 /kg/minute, or 1 kcal/kg/hour. MET values of 
different activities range from 1 MET at rest to 23 (running very fast at 23 km/hour). Light 
physical activity corresponds to an energy expenditure <3 METs, while moderate and 
vigorous physical activity correspond to an energy expenditure of 3-6 and >6 METs 
respectively. To calculate physical activity level (PAL), the sum of MET multiplied by time 
(hours) is divided by 24. Daily energy expenditure may be calculated by multiplying PAL by 
REE (24).   
Energy expenditure can be measured using indirect calorimetry (measuring oxygen 
consumption and/or carbon dioxide production and converted to EE using appropriate 
formulae), direct calorimetry (measuring the rate of heat loss from a subject) or by a number 
of non-calorimetric techniques (predicting EE by extrapolating from physiological 
measurements, e.g. doubly labelled water (DLW)) (25). 

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Figure 2. Energy expenditure distribution.  
TEE (100%) =  REE (50-70%) + DIT (10%) + PAEE (20-40%) 
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Energy intake comes from three main categories of macronutrients: carbohydrates, protein 
and fat, where energy densities are 4 kcal/g or 17 kJ/g for carbohydrates and protein and 9 
kcal/g or 38 kJ/g for fat. Digestibility and absorptive efficiency depends on many factors (fibre 
content, diet composition, preparation and gut flora). Such factors may cause variability in 
absorptive efficiency and therewith the net energy available for cell fuel (30).  
1.2.3 Genes interacting with environments 
Twin and family studies have shown that body weight is under genetic control. The role of 
genetics in the development of obesity has been extensively studied during the last few 
decades, with the results from twin studies estimating that 50-90% of the variance in BMI can 
be explained by genetic factors (31;32).  
Only a few monogenic disorders which affect the central regulation of appetite and lead to 
early, severe obesity have been identified. Such conditions are rare, except for mutations in 
the melanocortin-4 receptor (MC4R), which affects about 5% of morbidly obese patients (BMI 
40 kg/m) (33). 
Inherited disorders of the central regulation of food intake result in an increased feeling of 
hunger, increased snacking, decreased satiety and thereby obesity (34). However, obesity 
develops as a result of the interaction between genes and environments. While genes 

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themselves have not changed in the last few decades, environmental changes have been 
extensive. Interestingly, recent studies show that genetic susceptibility to obesity can be 
accentuated through low physical activity and high fat diets (35;36).  
We all have different heritable predispositions towards food intake and BMI. Genetic factors 
are, however, immutable, so to counter the effect of the obesogenic environment the 
controlling of energy balance (eating and exercise) is crucial. It is possible that progress in 
genetic research will contribute to the improvement of both the diagnosis of obesity and 
future efforts to tailor-make the treatment of obesity. 
 
1.3 Trends in obesity prevalence 
As of 2008 some 1.46 billion people worldwide were estimated to be overweight (BMI25 
kg/m2) and more than 500 million obese (BMI30 kg/m2). The high prevalence of overweight 
and obesity has become one of the major medical concerns of the century given that this 
condition is associated with increased morbidity and mortality (37).  
Reports from the latest National Health and Nutrition Examination Survey (NHANES) show 
that the prevalence of obesity among US adults (20 years) underwent a constant increase 
in the 1970s, rising from 15% to 35.5% among men and 35.8% among women in the period 
2009-2010 (38). Adjusted for self-reported biases, 15.5 million adult Americans, some 6.6% 
of the population, were morbidly obese (BMI40 kg/m2) in 2010 (39). The prevalence of 
morbid obesity was higher in women (8.2%) than in men (4.4%) (38). Globally, about 70% of 
morbidly obese subjects are women (40).  
Compared with NHANES data for the period 2003-2008 there was no significant change in 
the prevalence of obesity in 2009-2010 (41). This trend of a slowing in the prevalence of 
obesity in the US has also been observed in other countries (42-45). However, this trend shift 
has primarily been noted among highly educated subjects living in urban environments, 
which could indicate that the widening of the socioeconomic gap may have a detrimental 
effect upon the prevalence of obesity (42;45).  
In Norway the prevalence of obesity in the adult population doubled from 10% in 1984 to 
20% in 2003 (46;47). Data from the HUNT 3 study (Helseundersøkelsen i Nord-Trøndelag) 
for the period 2006-2008 show an increase in the prevalence of obesity in both men and 
women (22% and 23% respectively in HUNT 3)  compared to HUNT 1 (1984-1986) and 
HUNT 2 (1995-1997). This is shown in figure 3 and 4 (48). Especially worrying is the marked 

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increase of obesity among young men and women of childbearing age (48). Women account 
for about 70% of the morbidly obese population in Norway (49). 
Figure 3. The prevalence (%) of obesity (BMI30) in HUNT 1, 2 and 3 in men. 
(Figures 3 and 4 reproduced from (48) with permission from HUNT Research Centre). 
 
. 
Figure 4. The prevalence (%) of obesity (BMI30) in HUNT 1, 2 and 3 in women. 
 
 
 
1.4 The harmful effects of obesity  
More than 2000 years ago Hippocrates observed that “sudden death is more common in 
those who are naturally fat than in the lean” [quoted in (50)]. Today there is an overwhelming 
scientific basis for stating that obesity has several serious health effects, including impaired 
quality of life (51), increased morbidity and premature mortality (52;53). Morbid obesity is 
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currently defined as a severe chronic disease, causing psychological, social and somatic 
disadvantages, a disease where the need for prolonged treatment is of great importance 
(54;55). 
Raised BMI increases the risk of developing, coronary heart disease (CHD), hypertension, 
type 2-diabetes and many cancer forms (53;56-58). Furthermore, the incidence of non-fatal 
disorders such as osteoarthritis, chronic back pain, gallbladder disease and asthma is 
significantly increased in obese individuals (59).  
The relationship between obesity and obstructive sleep apnoea is also well established (60). 
Moreover, several endocrine changes are associated with obesity, where irregularities in the 
reproductive system are among the most severe (50). Obese men are characterised by 
decreased testosterone levels, whereas obese women can develop functional 
hyperandrogenism (61). The majority of women with polycystic ovary syndrome (PCOS) are 
obese and characterised by abdominal fat distribution (62). The clinical manifestations of 
PCOS may be menstrual irregularities (oligo- or amenorrhoea), hirsutism and infertility (63).  
In addition to the numerous severe health disadvantages obese individuals suffer from, the 
economic burden of obesity includes substantial medical costs and productive losses due to 
absenteeism, disability and premature deaths (64). In a recent systematic review of the direct 
costs of obesity, Withrow et al. concluded that on average obesity accounts for 0.7-2.8% of a 
country’s total healthcare expenditure, and that obese individuals have approximately 30% 
higher medical costs than normal weight individuals (65). Advanced calculations of the total 
health-care costs attributable to obesity suggest that obesity will account for 16-18% of the 
total health-care expenditure of the US by 2030 (66). Strategies for the prevention and 
effective treatment of obesity are therefore of great importance, not only as a means to 
facilitating good health but also as a means to promoting the economical well-being of both 
the individual and society. 
 
1.5 Diet and health  
In view of the considerations above, the French lawyer and politician Jean Anthelme Brillat-
Savarin (1755-1826) was remarkably prescient when in “The Physiology of Taste” (1825) he 
wrote: “The destiny of nations depends on the manner in which they are fed”.  
The associations between diet and health are very complex. Extensive international research 
during the last few decades has, however, provided the scientific evidence needed to 
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establish dietary recommendations and guidelines which promote public health and prevent 
chronic diseases (67;68).  
Obese individuals who lose weight may reduce their risk of non-communicable diseases 
(CHD, hypertension, type 2-diabetes and several cancer forms) (53;58). However, health-
promoting dietary changes will also enhance the preventative effect of weight reduction. The 
dietary treatment of obesity should thus have a double-pronged aim 1) to reduce weight 
through a negative energy balance and 2) prevent future disease.  
Diet and disease 
A diet rich in fruit, berries, vegetables, low fat dairy products, whole grains (equivalent to >25 
g fiber/day), fish twice a week (preferably fatty fish) and limited total- and saturated fat 
content is associated with reduced risk of developing stroke and coronary heart disease 
(69;70). A generally consistent body of evidence documents that increased fruit and 
vegetable consumption is associated with a dose-response reduced risk of having a stroke. 
For example, in analyses of the Nurses’ Health study and the Health Professionals’ Follow-
Up Study, persons in the highest quintile of fruit and vegetable intake (median 9.2 
servings/day in men and 10.2 servings/day in women) (1 serving  100 g) had a relative risk 
(RR) of 0.69 (95% confidence interval [CI] 0.52-0.92) compared to those in the lowest quintile 
(median 2.6 servings/day in men and 2.9 servings/day in women). An increment of 1 serving 
per day of fruits or vegetables was associated with a 6% lower risk of ischemic stroke (RR 
0.94; 95% CI, 0.90-0.99) (71). Intake of fruit, berries, vegetables and whole grain foods is 
associated with reduced risk of several cancer forms, while the intake of alcohol and both red 
and processed meat increases cancer risk and mortality (57;72;73). Data from the Health 
Professionals Follow-up Study (1986-2008) show a hazard ratio (HR) (95% CI) of total 
mortality for a 1-serving-per-day increase to be 1.13 (1.07-1.20) for unprocessed red meat 
and 1.20 (1.15-1.24) for processed red meat (73). The corresponding HRs (95% CIs) were 
1.18 (1.13-1.23) and 1.21 (1.13-1.31) for CVD mortality and 1.10 (1.06-1.14) and 1.16 (1.09-
1.23) for cancer mortality (73). Further, a diet with <30% of total energy from fat, <10 E% 
from saturated fat and rich in fibre and whole grain foods is associated with reduced risk of 
developing type 2- diabetes (74;75).  
High fibre intake, especially from whole grains and vegetables, is associated with lower 
mortality from CVD and cancer, circulatory, digestive and non-CVD non-cancer inflammatory 
diseases (HR per 10 g/day increased fiber intake: 0.90; 95% CI: 0.88-0.92) (76). Total dietary 
fibre intake has been found to be inversely associated with inflammatory markers in blood 
(interleukin-6, C-reactive protein and tumor necrosis factor-) (77;78). A possible mechanism 
that may explain this association is the production of short chain fatty acids (SCFA) from the 
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fermentation of dietary fiber in the colon (79). SCFA may affect gut microbiota and through 
this, although the mechanisms are not entirely clear, reduce systemic inflammation (79;80). 
Additionally, new findings suggest that gut microbiota might be involved in the development 
and maintenance of obesity (80). 
Nutritional guidelines 
In addition to ensuring the satisfactory development and functioning of the human body, the 
Nordic Nutrition Recommendations (NNR) for the intake of individual nutrients also aim to 
contribute to the risk-reduction of diet-associated diseases (Table 2) (24). 
Table 2. Recommended daily intake (RDI)1 of macro- and selected micronutrients (24). 
Nutrient RDI Nutrient RDI 
Energy (MJ) 9.2-11.8 Vitamin A (RE) 700-900 
Energy (kcal) 2200-2800 Vitamin D (μg) 7.5 
Protein E% 10-20 Vitamin E (mg) 8-10 
Total fat E% <30 Thiamin (mg) 1.1-1.4 
     SFA E% <10 Riboflavin (mg) 1.3-1.7 
     MUFA E% 10-15 Vitamin B6 (mg) 1.2-1.6 
     PUFA E% 5-10 Folate (μg) 300 
CHO, E% 50-60 Vitamin B12 (μg) 2 
     Sugar E% <10 Vitamin C (mg) 75 
     Fibre (g) 25 Calcium (mg) 800 
  Iron (mg) 15/92-9 
RE, retinol equivalents; E%, percentage of energy; SFA, saturated fatty acids; MUFA, 
monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; CHO, carbohydrates. 
1RDI values from NNR shown for women and men aged 31-60 years. 
2Pre-/postmenopausal women. 
 
Food-based dietary guidelines (FBDG) have been characterised as a “translation” of energy 
and nutrient recommendations, and include advice on food choice, food quantities, eating 
frequencies and eating patterns. The Norwegian FBDG aims to promote public health and 
prevent chronic diseases and is based on convincing scientific evidence which and can be 
summarised in the following key points (67): 
1. A largely plant-based diet rich in vegetables, fruit, berries, whole grains and fish, and 
with limited amounts of red meat, salt, added sugar and energy-dense food is 
recommended. 
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2. Maintenance of the balance between energy intake and energy expenditure is 
recommended.   
3. Eat at least 5 portions (á 100-150g) of vegetables, fruit and berries every day.  
4. Eat at least 4 portions of whole grains (70-90 g whole grain) every day. 
5. Eat fish equivalent to 2-3 dinner portions per week (in total 300-450 g). 
6. Daily consumption of low fat dairy products is recommended. 
7. Lean meat, low fat meat products and limited intake of red meat and processed meat 
are recommended (500g/week). 
8. Plant oil, liquid margarine and soft margarine are recommended. 
9. Drinking water is recommended. 
10. Limit one’s intake of added sugar. 
11. Limit one’s intake of salt (<6 g/day for women and <7 g/day for men). 
12. In some population groups supplements may be needed to ensure sufficient nutrient 
intake. 
13. Everyone should be physically active for at least 30 minutes daily. 
 
These national recommendations are in line with international reports on the prevention of 
non-communicable diseases, including obesity (57;68). 
 
1.6 Nutritional status in obese adults 
1.6.1 Macronutrients  
Obesity is often the result of a relatively small prolonged excess energy intake independent 
of macronutrient composition. However, recently it has been questioned whether 
macronutrient composition may affect weight changes (loss and gain) and weight 
maintenance. Recent reports demonstrate a positive association between fat intake and 
weight gain (81;82). Notably, increases in monounsaturated fat (MUFA) and polyunsaturated 
fatty acids (PUFA) were not associated with weight gain, but increases in intake of animal fat, 
saturated fat (SFA) and trans fatty acids were positively associated with weight change (82). 
Additionally, higher proportions of energy from protein and animal protein have been shown 
to be associated with higher risk of obesity (83). By contrast, Larsen et al. found that a 
modest increase in protein intake and a modest reduction in glycemic index improved weight 
loss maintenance (84). Data from both American and European cohorts show that a low-
fibre, high-fat diet is associated with the greatest increase in risk of overweight and obesity 
compared to a high-fibre, low-fat diet (85;86). The most energy-dense macronutrient, fat, 
therefore seems to contribute towards the development of obesity.       
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Although obese individuals have excess stores of adipose tissue due to a positive energy 
balance, they may have nutritional deficiencies due to poor dietary intake and/or altered 
nutrient absorption, distribution or metabolism of micronutrients (87;88).  
1.6.2 Micronutrients with special focus on vitamin D 
Compared to normal weight individuals, low levels of various micronutrients among 
overweight and obese adults have been demonstrated in a large cross-sectional study of 
adult Americans (NHANES III) (89). The data from this study demonstrates lower levels of 
beta-carotene, vitamin E, vitamin C, selenium and folate among obese persons compared to 
normal weight persons. Vitamin E, vitamin C and beta-carotene have been shown to protect 
low density lipoprotein cholesterol (LDL-cholesterol) against oxidation and thereby might play 
a role in inhibiting atherosclerosis (90;91). It has been hypothesised that the low 
micronutrient levels may reflect an increase in systemic and adipose tissue-specific oxidative 
stress in obese persons (89).  
In addition to insufficient levels of the aforementioned micronutrients, low levels of vitamin B-
6, B-12, ferritin, hemoglobin, copper, zinc, magnesium, albumin and phosphate have been 
reported in morbidly obese persons (92-95).  
Vitamin D  
Vitamin D is essential for calcium metabolism and bone mineralisation, though recent studies 
have shown that vitamin D may also play a central role in preventing some illnesses, 
including autoimmune disorders, some cancer forms, coronary heart disease and diabetes 
type 1 and 2 (96-102). There are two main forms of vitamin D, vitamin D2 (ergocalciferol) and 
vitamin D3 (cholecalsiferol). Vitamin D3 is the only form that is found naturally in human 
subjects. Exposure to sunlight is the main source of vitamin D, as vitamin D3 is synthesised 
in the skin from the precursor 7-dehydroksycholesterol through exposure to UVB radiation 
(103). There are relatively few good dietary sources of vitamin D3, but the best is oily fish, 
butter, margarine (fortified) and egg yolks (104). Cod liver oil and supplements account for a 
significant proportion of vitamin D intake in Norway (104). While vitamin D2 is the 
pharmaceutical form of vitamin D used in the USA (101), vitamin D3 is available as both a 
pharmaceutical and a supplement in Europe, Canada, Japan and India (103). Vitamin D3, 
(derived from UVB radiation or diet) enters the circulation and is hydroxylated in the liver to 
form 25-hydroxycholecalciferol (25(OH)D), which is the major circulating metabolite and a 
widely used marker of vitamin D status in humans. Further, 25(OH)D is hydroxylated in the 
kidneys to 1,25-dihydroxycholecalsiferol (1,25(OH)2D) which is the biologically active form 
of vitamin D. The action of vitamin 1,25(OH)2D is mediated through vitamin D receptor. 
Vitamin D receptor is present in most human tissues, including macrophages, smooth 
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muscle cells, pancreatic -cells, epithelial cells and osteoblasts (105). The vitamin D receptor 
may underlie the diverse effects of vitamin D and provide a mechanistic basis for the link 
between vitamin D deficiency and a number of the disorders mentioned above (105). 
Measures of vitamin D status 
Although 1,25(OH)2D is the biologically active form of vitamin D, it is not an ideal measure of 
vitamin D status. One reason for this is the rapid circulating half-life of 1,25(OH)2D of 4-6 
hours, another the fact that circulating levels of 1,25(OH)2D are a thousand folds lower than 
25(OH)D (106). Additionally, vitamin D deficiency causes reduced intestinal calcium 
absorption which in turn transiently lowers ionised calcium. This is recognised by calcium 
sensors in the parathyroid glands, which then increase the secretion of parathyroid hormone 
(PTH) (107). PTH regulates calcium metabolism by increasing calcium re-absorption in the 
kidneys, increasing calcium release from the skeleton and by increasing renal production of 
1,25(OH)2D (108). The increased PTH-levels in a vitamin D deficient patient will thus result in 
normal or elevated levels of 1,25(OH)2D which make this metabolite unsuitable as a measure 
of vitamin D status.  
The only vitamin D metabolite used to measure vitamin D status is 25(OH)D. Circulating 
25(OH)D has a half-life of 2-3 weeks (106). Although the definition of vitamin D deficiency is 
widely debated, most agree that a concentration of 25(OH)D <50 nmol/l is an indication of 
vitamin D deficiency (101;103;109). 
Obesity and vitamin D levels 
It is well established that obesity is associated with low serum levels of 25(OH)D (110-114). 
The circulating 25(OH)D-levels are inversely correlated with diverse measures of obesity 
(BMI, fat mass and waist circumference) (115;116). This is probably due to both decreased 
bioavailability from cutaneous and dietary sources, sequestration of vitamin D in adipose 
tissue and low exposure to sunlight (88;117). Obese persons respond less effectively to 
vitamin D-supplementation and ultraviolet radiation than normal weight individuals (115;117). 
Secondary hyperparathyroidism, which may result in bone weakening and joint pain, has 
been reported in conjunction with vitamin D deficiency in obese subjects (95;118).   
Although there is growing evidence that obesity causes vitamin D deficiency, other possible 
cause-effect relationships have been explored. Whether vitamin D deficiency contributes to 
obesity is also a current discussion (119).  
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1.7 Weight loss treatment  
1.7.1 Non-surgical interventions 
Expected long-term (1 year) weight reduction as a result of lifestyle intervention (calorie 
restricted diets, physical activity and behavioural counselling) in severely obese subjects is 
lower than that resulting from surgical treatment, 5-20% vs. 30% respectively (49;120;121). A 
significant, meaningful weight loss (i.e. 5%) can be achieved non-surgically in institutions, 
primary care settings and clinical centres (122;123). However, a weight loss of at least 10% 
is a desirable and achievable goal in non-surgical treatment of severe obesity (120). There 
have been calls for greater effort and research such as to improve weight loss maintenance 
strategies (120).  
Non-surgical treatment options include dieting, physical activity, drugs and behavioural 
interventions. To assess which type of intervention contributes most to successful weight-
loss followed by long term maintenance of achieved weight-loss is complex, but adherence 
to any program seems to be an essential component of success. 
Dietary intervention 
Reducing energy intake is one of the most widespread strategies for achieving weight loss. 
This can be done by reducing total intake of calories from one or more macronutrients 
(protein, carbohydrate and/or fat).  
Low fat diets are widely used in order to help patients lose weight by reducing energy and fat 
intake and increasing intake of whole grain, fruit and vegetables. These diets are often in 
accordance with the nutritional recommendations made by authorities to prevent obesity and 
several diseases (24;68). Diets with low glycaemic index contain carbohydrates digested and 
absorbed more slowly and are therefore supposed to increase satiety. A systematic review 
comparing diets of low glycaemic index or low glycaemic load with conventional restricted 
energy low-fat diets has shown a small but significant better effect (weighted mean 
difference, -1.09 kg, CI-1.99 to -0.18 kg) of the former on weight loss after 6 months follow up 
after intervention (124). Low carbohydrate diet is a term used to describe diets with a wide 
range of carbohydrate content. A very low carbohydrate diet, of which the Atkins diet 
probably is the best known, provides <30 g carbohydrate per day. Debates about which diet 
gives best results in terms of weight loss and maintenance are ongoing. Several randomised 
controlled trials have compared weight-loss diets with different macronutrient composition 
(125-128). Although low-carbohydrate diets seem to give a greater short-term weight-loss 
than more traditional low-fat diets, the long-term results (2 years) are comparable (125;128).   
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Very-low-calorie diets (VLCD), providing < 800 kcal/day produce rapid weight loss and may 
be recommended for people with severe obesity. Importantly, several studies indicate that 
greater initial weight loss improves long-term weight maintenance (122;129;130). It has been 
suggested that weight reduction achieved by initial use of VLCD followed by a management 
programme including dietary counselling, as well as a low-fat energy restricted diet and a 
appropriate physical activity programme, may both improve sustained weight maintenance 
(130). 
In a large-scale pan-European controlled dietary intervention study (the Diet Obesity and 
Genes study – DIOGenes) diets varying in protein and glycaemic index were assessed after 
an 8-week VLCD-initiated weight-loss period for their effects on long-term weight loss 
maintenance and cardiovascular risk factors (84;131). Mean participant weight loss after 
these 8 weeks was 11.0 kg. Thereafter participants were randomised to 1 of 5 ad libitum 
diets for 26 weeks. The diets were either high or low protein or high or low glycaemic index in 
4 combinations or control. Although the differences in weight maintenance were small, 0.93 
kg less (95% CI, 0.31-1.55) in the groups assigned to a high-protein diet compared to those 
assigned to a low-protein diet and 0.95 kg less (95% CI, 0.33-1.57) in the groups assigned to 
a high-glycaemic-index diet compared to those assigned to a low-glycaemic index diet, the 
authors concluded that a modest increase in protein content (from  17% of total energy 
intake to  22 %) and a modest reduction in the glycaemic index (from  61 to  56), resulted 
in better weight loss maintenance (84). This effect may be ascribed to the satiating effect of a 
higher protein and fibre content in the diet (132;133). 
 Elements of lifestyle intervention programs and drug treatment 
Currently a wide range of lifestyle intervention programmes affecting health behaviours are 
available. Such programs generally combine restriction of calorie intake, increased physical 
activity and/or drugs. The behavioural approaches followed in such programmes usually 
include keeping records of food intake and physical activity, nutrition education, meal 
planning, controlling the stimuli which activate the desire to eat, individual social support and 
psycho-education in groups. Although the use of the drugs orlistat, sibutramine and 
rimonabandt has been shown to increase weight reduction in obese subjects (134), only 
orlistat is currently available in Europe after both sibutramine and rimonabandt were 
withdrawn from the market due to their adverse side-effects.  
A systematic review and meta-analysis of weight-loss clinical trials with a minimum of one 
year follow-up showed a relatively moderate mean weight loss of 5 to 8.5 kg (5 to 9%) after 
the first 6 months as a result of  different interventions involving energy-reduced diets and/or 
exercise, and/or weight-loss medications (sibutramine or orlistat) (135). A mean weight-loss 
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of 3 to 6 kg (3-6%) was maintained in studies extending to 2 years. Although some weight 
was regained, the authors concluded that weight loss can be maintained through weight-loss 
interventions combining energy-reduced diets and exercise, and that the addition of weight-
loss medication enhances weight-loss maintenance somewhat (135).  
It has been demonstrated that intensive behavioural intervention in specialised weight loss 
centres can be a safe and effective treatment option for severely obese individuals (136). In 
one study, 1531 patients with severe obesity (BMI40 kg/m2) were treated in three clinics. Of 
these 1100 completed a 12-week “Core”-intervention class followed by “Ongoing”-classes 
until participants reached their weight goal and finally entered the “Maintenance Program” (or 
exited the program). The weight loss options in the “Core”- and “Ongoing”-classes included 
defined treatment components: weekly attendance, phone calls, record keeping, intake of 
either a VLCD ( 520 kcal/day) or a low-energy-diet (LED) (1000 kcal/day) and regular 
physical activity. The “Maintenance Program” included weekly attendance and phone calls, 
record keeping, restricted energy intake and physical activity. The average weight loss of 
female completers was 31 kg (24% of initial weight) and 43 kg for male completers (27% of 
initial weight) over 39 weeks. Follow-up weight loss after 72 weeks was on average 23 kg 
(59% maintained weight loss) (136).  
In a recent review of the overall efficacy of lifestyle interventions (including diet, exercise and 
psychological interventions) there was little evidence to indicate that any one intervention is 
more effective than any other (137). However, there is evidence of an additive effect of a 
combination of diet, exercise and behavioural interventions in the treatment of obesity. 
Furthermore, there was no evidence that any dietary strategy is more effective than any 
other, making it essential to encourage individuals to adopt a diet they can accept in the 
long-term (137).  
Weight loss maintenance 
Losing weight may be difficult and maintaining weight loss even more complex. Successful 
weight loss maintenance has been defined as “individuals who have intentionally lost at least 
10% of their body weight and kept it off at least one year” (138). It is of great importance to 
identify the strategies used by successful weight loss maintainers. The National Weight 
Control Registry (NWCR), a database of more than 4000 adult individuals who have lost  
13.6 kg and maintained this at 1 year follow-up, provides unique information in this respect 
(139). The members in NWCR have used different strategies to achieve weight loss, but 
almost without exception they have combined dieting with physical activity. Early publications 
document the behaviours used by members to maintain their weight loss. Four strategies 
have been clearly identified: consuming a low-calorie (1381 kcal/d), low-fat diet (24% of total 
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energy intake), consuming breakfast daily, partaking in high levels of physical activity (1h/d 
of moderate-intensity activity such as brisk walking) and weighing oneself frequently 
(140;141). Consuming a diet with limited variation in all food groups may contribute to the 
low-energy diet characteristic for successful long-term weight loss (142). 
Another strategy to maintain weight loss has more recently been reported by Wing et al. 
(143). They found that face-to face intervention in a self-regulation program for maintenance 
of weight loss (mean 19.3 kg of body weight lost in the previous 2 years) combined with daily 
self-weighing improved the maintenance of weight loss (weight gain <2.3 kg over 18 months)  
compared with receiving the programme over the Internet or by receiving quarterly 
newsletters (control group) (143). Participants in the two intervention groups in this study 
were asked to report their weight weekly through an automated telephone system (face-to-
face group), or a web-based form (the Internet group). Those who reported a weight gain of 
less than 1.4 kg (from starting weight) were in the “green zone” and provided positive 
reinforcement, those gaining 1.4-2.2 kg were in the “yellow zone” and were instructed to use 
problem-solving skills to bring their weight back into the “green zone”, whilst  those gaining 
2.3 kg were in the “red zone” and encouraged to restart active weight-loss efforts (low-
calorie, low-fat diet and increased physical activity) (143).    
Anderson et al. assessed long-term weight-maintenance in a group of patients (n=118) who 
initially achieved a weight-loss of 45 kg (100 pounds) by undergoing intensive behavioural 
intervention in specialised weight loss centres (136;144). At an average of 5 y of follow-up 68 
patients had maintained a weight loss of 30 kg of initial body weight (49.3% of initial weight 
loss). This shows that intensive behavioural intervention can be an effective option in the 
treatment of severe obesity (144).  
Behavioural interventions include dietary, exercise and behavioural approaches utilised to 
reduce and maintain weight loss. Behavioural techniques utilised to reduce reinforcement of 
unhealthy eating behaviours and reinforce healthy eating behaviours include cue avoidance, 
practicing eating restraint, resisting social pressure to eat and relapse prevention training. 
High-intensity (weekly) counselling (by phone, internet and/or in groups) allied with dietary 
changes and physical activity may improve weight loss and maintenance in severely obese 
subjects (136).   
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1.7.2 Bariatric surgery 
According to national and international guidelines, bariatric surgery may be an appropriate 
alternative for morbidly obese individuals who have failed to lose weight or maintain long-
term weight loss despite appropriate lifestyle interventions or other medical care (55;145).  
Bariatric surgery may be offered to treatment seeking subjects with morbid obesity; BMI40 
kg/m2 or BMI 35-39.9 kg/m2 with at least one obesity related co-morbidity, (e.g. type 2 
diabetes, hypertension, obstructive sleep apnoea, cardio-respiratory disease, arthrosis, 
psychological problems). Contraindications to bariatric surgery include severe respiratory 
failure, heart or kidney failure, failure to comply with prolonged medical follow-up, non-
stabilised psychotic disorders, severe depression or personality disorders, alcohol- and/or 
drug-abuse (145;146). In Europe, different bariatric surgical techniques are practiced, 
preferably in tandem with laparoscopic procedures. The Roux-en-Y gastric bypass (RYGB) 
(Figure 4), adjustable gastric banding, sleeve gastrectomy (Figure 4) and biliopancreatic 
diversion with duodenal switch are examples of current bariatric surgical techniques (145). Of 
these, adjustable gastric banding and sleeve gastrectomy operations are restrictive surgical 
procedures which limit food intake, whereas RYGB and biliopancreatic diversion with 
duodenal switch are surgical methods which combine the effects of limiting food intake and 
the nutrients absorbed (145).   
Today, laparoscopic RYGB is the most common bariatric procedure both worldwide and in 
Norway (147;148). As much as 90% of surgical procedures in Norway today are the RYGB 
operation (Figure 4) (146). Although the RYGB is mainly a restrictive procedure and the 
weight-reducing effect is principally caused by reduced calorie-intake, the operation 
additionally causes moderate malabsorption and changes in the gut hormonal and neuronal 
responses which affect satiety, hunger, metabolism and insulin sensitivity (145;148). In the 
Nordic countries the standard RYGB procedure includes a small gastric pouch (20-30 ml), a 
biliopanceratic limb of approximately 75 cm, an alimentary limb of 150 cm and a common 
channel of 2 to 5 metres (148;149). If the patient has a BMI>50 kg/m2, then a very long limb 
gastric bypass procedure with an alimentary limb >150 cm and a shorter common channel 
may be recommended (148).  
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Figure 4. Roux-en-Y gastric bypass (left), gastric sleeve (right).  
(Figure by K.Toverud) (146). 
 
Surgical outcomes are often measured by improvement or resolution of co-morbidity and lost 
excess weight, where excess weight is defined as preoperative weight minus ideal weight 
(BMI=25 kg/m2). Several studies confirm that in both the above respects, bariatric surgery 
achieves better results than dietary intervention, physical activity, behaviour modification and 
pharmacotherapy (150). In a systematic review including more than 22.000 patients, 
Buchwald et al. reported mean percentage excess weight loss [= (weight loss/excess weight) 
x 100) approximately 2 years after bariatric surgery to be 62% for RYGB, 70% for 
biliopancreatic diversion with duodenal switch and 48% for gastric banding (151). These are 
significantly greater weight losses compared to severely obese patients undergoing lifestyle 
intervention. In a recent report from the Look AHEAD trial, individuals participating in a 
lifestyle intervention program lost 9% of their initial body weight after 1 year (152), which is 
comparable to the findings in our group (49). In their meta-analysis of surgical treatment of 
obesity Maggard et al. found surgery to be more effective than non-surgical treatments for 
weight loss and improvement of co-morbidity in patients with BMI 40 kg/m2, however, they 
concluded that the efficacy of the two treatment options for less obese people need further 
investigation (153).  
Several findings on morbidity and mortality have been reported in the non-randomised, 
prospective, controlled Swedish Obese Subjects (SOS) study. In this ongoing study, 2010 
obese patients underwent bariatric surgery (13% gastric bypass, 19% banding and 68% 
Gastricsleeve
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vertical banded gastroplasty) and 2037 matched controls received usual care in the Swedish 
primary health care system (121). The majority of patients in this study were operated upon 
with techniques which are rarely used in the Nordic countries today. The average weight loss 
at 10-year follow up was 16% in the surgical group while weight increased by an average of 
1.5% during this time in the conventional group receiving usual care in the Swedish primary 
health care system (154). Although large weight loss is more often achieved by bariatric 
surgery than conventional treatment, there was great variation in weight reduction among 
surgical patients after 10 years. About 12% lost 30% of their baseline body weight, almost 
25% lost 20-29.9%, 30% lost 10-19.9%, about 25% lost <10%  and 9% gained weight. In the 
surgical subgroups there were significant differences in 10-year weight loss, with about 13% 
weight loss for banding, 17% for vertical banded gastroplasty and 25% for gastric bypass. In 
the “usual care” group 15% lost 10% and 54% gained weight during the 10-year follow-up 
period (154). After an average of 11 years follow-up, mortality in the surgical group 
significantly decreased compared to usual care (121). 
After 10 years follow-up the recovery rates of type 2 diabetes, hypertriglyceridemia, low 
levels of HDL-cholesterol, (although not for hypercholesterolemia), hypertension and 
hyperuricemia were significantly higher in surgically treated patients than in conventionally 
treated ones (155). A recent SOS report showed bariatric surgery to be associated with 
reduced incidences of long-term cardiovascular events (median follow-up 15 years, range 0-
20 years) compared with usual care (156).   
Other weight related co-morbidities and conditions such as cancer, sleep apnoea, 
depression and sexual dysfunction in both men and women have been shown to improve 
after bariatric surgery (151;157-159). Additionally, when close supervision is conducted 
before, during and after pregnancy following bariatric surgery pregnancy outcome, maternal 
and fetal health improve (160).   
Nutritional consequences of RYGB  
The RYGB is considered mainly a restrictive procedure, but also has a malabsorptive 
component as the small bowel is reconfigured (Figure 4). In addition, the neuronal and gut 
hormonal changes will reinforce the weight loss process. These changes will individually and 
collectively affect the patients food choice, and thereby the intake and absorption of macro- 
and micronutrients.  
During the first 12 months after the operation around 50% of patients experience 
gastrointestinal discomfort which gradually subsides (49;161). During the first months many 
patients experience vomiting or “spitting up stuck food” due to overeating or inadequate 
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chewing (162). This type of occasional vomiting is normally tolerable. If vomiting becomes 
frequent, low potassium, magnesium and/or vitamin B1 levels may occur, requiring 
replacement. And if vomiting occurs when consuming solid foods, particularly if this 
intolerance develops 6 months or more after surgery, it could be a symptom of stricture and 
stomal stenosis requiring treatment (162). Varying degrees of food aversion may be caused 
by the dumping syndrome, which is usually precipitated by ingestion of food with a high 
sugar and/or fat content (161). The multi-factorial mechanisms involved in the dumping 
syndrome are not fully understood, but symptoms typically occur 10-30 minutes 
postprandially and may be explained by accelerated gastric emptying of hyperosmolar 
content into the duodenum, which leads to fluid shifts from the intravascular compartment 
into the intestinal lumen. The clinical manifestations are often divided into gastrointestinal 
and vasomotor symptoms (163). The gastrointestinal symptoms include early satiety, 
nausea, cramps and acute diarrhoea, while sweating, palpitations, dizziness and a strong 
desire to lie down are typical examples of vasomotor symptoms. Most patients with dumping 
have a combination of gastrointestinal and vasomotor symptoms (163).   
Dietary modifications will prevent most cases of dumping symptoms. These modifications 
include: dividing daily food intake into 6-8 small meals, restricting fluid intake during meals 
(avoiding liquids for at least half an hour after meals), reducing intake of simple sugars (e.g. 
sweets, cakes, sodas) and preference for complex carbohydrates (e.g. unsweetened cereals, 
fresh fruit and vegetables, potatoes and pasta). Milkshakes, sweetened yoghurt, ice cream 
and chocolate milk are usually poorly tolerated and should be avoided. The supine position 
for 30 minutes after meals may reduce postprandial hypotension by delaying gastric 
emptying and improving venous return (163).  
Postprandial hypoglycaemia, also called “late dumping”, occurs 1-3 hours after a meal and is 
characterised by hypoglycaemic symptoms (shakiness, hunger, perspiration, concentration-
difficulties and/or decreased consciousness) and/or symptoms similar to dumping syndrome. 
Severe hypoglycaemia is considered a rare consequence of RYGB and is estimated to occur 
in up to 7% of patients (49;164;165). Treatment should begin with dietary modifications, 
including low carbohydrate -and high protein meal content (166).    
Supplementation with dietary fibres (bran, methylcellulose, pectin and guar gum) have been 
tested and shown to alleviate hypoglycaemia by forming gels with carbohydrates; they thus 
delay glucose absorption and prolong transit time (167;168). Treatment of postgastric bypass 
hyperinsulinemic hypoglycaemia may additionally require medical and/or surgical treatment 
(164). 
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Patients who have undergone bariatric surgery can develop diverse nutritional deficiencies 
which can cause severe morbidity if not treated.  
Due to reduced protein intake or absorption postoperatively, protein malnutrition may occur. 
After malabsorptive procedures with alimentary limb >150 cm the risk of protein malnutrition 
increase and hypoalbumiemia has been reported in about 6% of patients (169).  
The data available on vitamin and mineral status after bariatric surgery is scarce, but the 
most frequent deficiencies reported after gastric bypass surgery are insufficient levels of 
vitamin B 12, iron, folic acid, vitamin D and calcium (92;170;171). It has been shown that a 
standard multivitamin supplement cannot prevent these micronutrient deficiencies 2 years 
after RYGB. Gasteyger et al. reported the following proportions of patients with insufficient 
vitamin-/mineral levels 2 years postoperatively: 80% had insufficient levels of vitamin B12, 
60% of iron, 60% of vitamin D and calcium, and 45% of folic acid. Furthermore, 13% had 
insufficient levels of vitamin B6, 13% of magnesium, 12% of zinc and 4% had inadequate 
vitamin B1 levels (170). As a consequence, almost all patients needed at least one additional 
nutritional supplement 1 and 2 years postoperatively (86 and 98% respectively) (170). 
Vitamin A deficiency has also been reported in 17% of patients 2 years after RYGB surgery 
(172). Another example of serious illness after bariatric surgery is Wernicke encephalopathy 
caused by severe thiamine (vitamin B1) deficiency. This condition may lead to death or 
lasting disability if not treated immediately (173). A common risk factor for developing this 
quite rare condition (1 out of 500 patients) is frequent vomiting the first weeks after surgery 
(173).  
Both clinicians and patients should be aware of the risks of nutritional deficiencies following 
rapid weight loss after bariatric surgery. To prevent this, thorough dietary instructions should 
be included in patient information programmes both prior to bariatric surgery and in the 
follow-up period post-surgery (171). 
 
1.8 Assessment of dietary intake 
All the traditional measurement methods of habitual food intake; weighed food records, 
dietary history, 24-hour dietary recalls and food frequency questionnaires (FFQ) include 
varying levels of dietary reporting errors. One major challenge is the tendency human beings 
have to underreport their energy intake (EI), with this especially pronounced among obese 
individuals (174).   
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The FFQ method is extensively used to measure a person’s habitual dietary intake over a 
predefined period of time and to investigate relationships between diet and health in 
nutritional epidemiologic studies. Although the FFQ, as a retrospective method, has inherent 
measurement errors including incorrect memory of past food choice and amount consumed, 
it is a relatively inexpensive and easy tool to administer. The FFQ method is well established 
and validated for assessing habitual diet among adults in Norway (175-178). 
Validation of reported dietary intake 
EI should meet the body’s total energy requirements. When EI equals total energy 
expenditure weight maintains stable. Reported EI is a way of measuring total food intake. A 
valid (or accurate) report of EI measure is the true intake during a given period of time. The 
habitual intake is a person’s intake over a prolonged period of time (weeks, months or years). 
Even if food intake can vary widely with season and time, the methods used for validation of 
reported EI rest on the assumption that EI equals total energy expenditure in a weight-stable 
situation (179).  
The doubly labelled water (DLW) technique is considered the “gold standard” for measuring 
TEE. The method involves measuring the urinary excretion of stable isotopes of deuterium 
and oxygen-18 after administration of a predefined dose of the DLW. However, since the 
DLW measurement period is usually 14 days in adults, the method cannot account for 
monthly or seasonal fluctuations, and is not necessarily a measure of habitual TEE (179). 
TEE obtained by using the DLW method is frequently used to validate EI calculated from 
food records, dietary histories and FFQs (180;181). If the TEE measured by DLW is higher 
than reported EI then the reported EI has been underestimated. Even if DLW is the preferred 
validation method, it is too costly and technically complicated for routine validation of 
reported EI.  
The Goldberg method is a technique whereby reported EI is evaluated against estimated 
energy requirements, and is now widely used (182). This technique involves using an 
equation to predict TEE. TEE is calculated from the product of BMR (estimated) and physical 
activity level (PAL). Values for variation in reported EI, BMR and PAL may be applied to 
classify misreporters, as suggested by Black (183). This method is currently being used to 
assess reported EI in dietary surveys in a simpler, cheaper and more feasible manner than 
the DLW method (183;184). In comparison with the DLW method, the Goldberg method is 
considered a reasonable approach to identifying underreporting in both 24-hour recalls and 
FFQs (185). 
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Introduction summary 
Obesity is one of the main medical challenges of our time. Traditionally malnutrition has been 
linked to energy deficit. However, malnutrition can also result from poor dietary quality and/or 
increased requirements. Both obesity and a diet of poor quality pose a significant health risk. 
With this in mind it is important to be aware of the high prevalence of various micronutrient 
deficiencies morbidly obese subjects may suffer from prior to treatment. One of the best 
known examples is vitamin D deficiency. 
Although lifestyle intervention in the form of reduced energy intake and physical activity is the 
cornerstone of treatment of morbid obesity, the number of patients undergoing bariatric 
surgery is rapidly increasing. The current understanding of how food and nutrient intake 
change after bariatric surgery and lifestyle intervention is inadequate. The main aims of this 
thesis were to investigate the changes in nutrient and food group intake and to examine 
changes in blood levels of selected vitamins 1 year after lifestyle intervention and gastric 
bypass surgery. Additionally, we sought to explore the prevalence of vitamin D deficiency in 
a large cohort of treatment seeking morbidly obese men and women in Norway. We 
expected that a better understanding of these issues might help health care professionals to 
improve the dietary counselling of morbidly obese patients seeking weight loss treatment. 
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2 AIMS OF THE THESIS 
The specific aims of the studies in this thesis are: 
1. To assess and compare changes in the intake of specified food groups and energy 
yielding nutrients in the context of recent food based dietary guidelines and nutrition 
recommendations in patients undergoing either gastric bypass surgery or intensive 
lifestyle intervention during a 1-year non-randomised clinical intervention trial. 
 
2. To assess the 1-year changes in vitamin A, B1, B6, folic acid, B12, C, D and E 
concentrations in gastric bypass patients taking predefined supplementation, and to 
compare these vitamin changes with those of patients undergoing an intensive camp-
based lifestyle intervention.  
 
3. To investigate the effect of gender on vitamin D status in a large cohort of morbidly 
obese Norwegian patients, and to explore whether a possible gender based 
difference in vitamin D status might be explained by variations in overall and/or 
abdominal obesity.   
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3 MATERIALS AND METHODS 
3.1 Study designs 
The results in this thesis are based on longitudinal data from the one-year non-randomised 
controlled clinical MOBIL study (Morbid Obesity treatment, Bariatric surgery versus Intensive 
Lifestyle intervention) (Paper I and II) and cross-sectional data from The Morbid Obesity 
Biobank Registry (Paper III). Participants in all three studies were morbidly obese (Table 3).  
Table 3. Study design and sample size. 
Paper N Population Study design 
I 72 gastric bypass 
54 lifestyle intervention 
 
Men and women in the 
MOBIL study 
Non-randomised 
controlled study   
II 27 gastric bypass 
23 lifestyle intervention 
 
Men and women in the 
MOBIL study 
Non-randomised 
controlled study   
III 2026 Men and women in the 
Morbid Obesity Biobank 
Registry 
Cross-sectional study 
 
3.2 Participants 
All participants were referred from local hospitals to the Morbid Obesity Centre (Vestfold 
Hospital Trust) for weight reducing treatment. The Morbid Obesity Centre is located in 
Tønsberg and is a public tertiary care centre serving approximately one million inhabitants in 
Southern Norway. The centre was established in September 2004 and is one of two tertiary 
care centres in South-East Norway Regional Health Authority which treats morbidly obese 
patients. The main tasks of the centres are to evaluate, assess and treat morbidly obese 
persons, as well as to plan and carry out obesity-related research projects and educate and 
support other health care personnel responsible for obesity treatment (link: www.sykehuset-
vestfold.no/sso).  
3.2.1 One year non-randomised clinical trial (Paper I and II) 
Papers I and II include patients from the MOBIL study. The flow of the study participants is 
shown in Figure 5. Between December 2005 and May 2006, 228 consecutive patients were 
pre-screened for inclusion in the trial. One hundred and eighty-one patients who met the 
criteria for inclusion in the study were referred to an extensive screening examination 
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including oral glucose tolerance test, 24-hour ambulatory blood pressure monitoring, 
somnography, pulmonary function test, quality of life questionnaires and structured dietary 
interviews. Of the 181 patients who completed the screening, 146 were enrolled in the study. 
Of these, 80 were accepted for gastric bypass surgery and 66 for a camp-based intensive 
lifestyle intervention program.  
Allocation to treatment was the result of a joint decision made between patient and physician. 
The decision was based on thorough assessments by a multidisciplinary team; internist, 
dietitian, nurse, physiotherapist and surgeon (in cases of surgery). The health-team informed 
patients about possible risks and benefits of the two treatments.  
One year follow up was completed for both groups by June 2009. Of the 146 patients 
enrolled in the MOBIL study, 139 (95%) completed the one-year follow-up period (n=63 in the 
lifestyle intervention group and n=76 in the surgery group) (49).   
Paper I  
After the exclusion of 13 patients who declined to undergo dietary interviews (9 at baseline 
and 4 after intervention), 126 patients (54 in the lifestyle group and 72 in the surgery group) 
had completed the dietary interviews both at baseline and after one year follow up and were 
subsequently included in the dietary analysis. Patients in the surgical group were significantly 
younger and heavier than those in the lifestyle group [mean (SD) age: 43 (11) versus 47 
(11)] years (P=0.034) and BMI: 46 (6) versus 43 (5) kg/m2 (P<0.001)]. 
Paper II  
The first 64 potential participants in the MOBIL study had their vitamin concentrations 
measured in a separate vitamin status study (93). Of the 64 patients screened for enrolment 
into the trial, 53 were included and 50 (27 in the surgery group and 23 in the lifestyle group) 
completed the one year follow up. The groups did not differ significantly in age at baseline 
[median (25th-75th percentiles)]: surgery group 44 (36-50) versus lifestyle group 45 (35-59) 
years, P=0.38. Patients in the surgery group had, however, significantly higher BMI than 
those in the lifestyle group: 46 (42-59) versus 40 (39-44) kg/m2, (P<0.001). 
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Figure 5. Flow of patients completing dietary interviews in the MOBIL study. 
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3.2.2 Cross sectional study (Paper III) 
The study in Paper III had a cross-sectional design and included patients from The Morbid 
Obesity Biobank Registry. All patients who have attended the Morbid Obesity Centre since 
November 2005 have, after giving informed consent, been included consecutively in the 
Registry. The Registry comprises of clinical data and laboratory results from the first visit at 
the Centre.  
Paper III included all the morbidly obese patients registered at the Morbid Obesity Biobank 
Registry in the period November 2005 – June 2010. Of the 2140 patients considered for 
inclusion, 39 non-morbidly obese patients with BMI<35 kg/m2 and 75 patients with missing 
measurements for either 25(OH)D (n=48), BMI (n=11) or both (n=16) were excluded. The 
remaining 2026 were included in the analysis. In addition, a subgroup of 154 patients 
participating in the MOBIL study and examined between December 2005 and May 2006 
were evaluated in order to assess total vitamin D intake and macronutrient composition.  
 
3.3 Clinical characteristics 
Patient demographic data, medical history, smoking habits and intake of vitamin 
supplements were recorded using standardised forms (Paper I-III). Anthropometric measures 
were made with patients in an upright position wearing light clothing and no shoes. Waist 
circumference was measured at the midpoint between the lowest rib margin and the iliac 
crest, whilst hip circumference was measured at the level of the major trochanter. Neck 
circumference was measured below the larynx and perpendicular to the long axis of the 
neck. Waist, hip and neck circumference were measured with a tape measure to the nearest 
cm. Height was measured with a wall mounted stadiometer to the nearest 0.5 cm, whilst 
weight was measured to the nearest 0.1 kg.   
Patients with at history of type 2 diabetes or a fasting serum glucose concentration 7 mmol/l 
were classified as having type 2 diabetes (Paper II and III) (186). Ischemic heart disease was 
defined as either a history of percutaneous coronary artery bypass graft surgery or 
myocardial infarction and elevated C-reactive protein concentration as a level 7 mg/l (Paper 
III).  
In paper III, vitamin D deficiency was defined as serum 25(OH)D<50 nmol/l and secondary 
hyperparathyroidism as serum parathyroid hormone concentration >6.9 pmol/l and 
concomitant serum calcium <2.54 mmol/l. Season of blood sampling was defined as either 
winter (1 November through 28 February) or summer (1 March through 31 October). 
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3.4 Dietary intake  
Dietary intake was assessed by using a validated FFQ including 180 food items, beverages 
and courses grouped together according to the traditional Norwegian meal pattern (175-
177;187). The FFQ was used as a structured interview lasting for 1 to 2 hours. The optically 
readable FFQ used is designed to measure the daily habitual food intake of the adult 
population in Norway and is suitable for estimating various macro- and micronutrients, 
including dietary supplements (175).  
The interviews were conducted by registered dieticians. In all three studies patients were 
asked to describe their habitual dietary intake during the year previous to their intervention 
(baseline registration). Patients were asked to report their intake (frequency and amount) of 
the various food items and beverages (per day, per week or month) as fully as possible. 
Units (e.g. slices and pieces) and household measures were used to estimate portion sizes. 
In paper I and II the dietary assessments were repeated 1 year after either surgery or the 
start of the camp-based lifestyle intervention. The FFQ data was scanned using Teleform 
10.0 (Cambridge, UK). The daily intake of food, energy and nutrients were calculated using 
the Kostberegningssystem computer software (version 6.0, University of Oslo), and were 
based on data from the Norwegian food composition table (Norwegian Nutrition Council, 
1995).  
Underreporting 
In Paper III individuals underreporting total EI were identified by calculating cutoff levels for 
acceptable reported EI using Black’s equations and practical guidelines (183;184). Basal 
metabolic rate was estimated by using Mifflin-St Jeor’s equations (188). A physical activity 
level indicating low activity level for each gender was used (1.56 for women and 1.55 for 
men). Male patients were classified as under-reporters if EI:basal metabolic rate was < 1.10, 
whilst for female patients the threshold was <1.11.  
 
3.5 Laboratory analyses  
Blood sampling was performed by vein puncture after an overnight fast. Vitamin assay 
samples clotted for 30 minutes at room temperature. Thereafter, serum was separated by 
centrifugation. Samples were stored at either -20C or -80C (for vitamin B-2 and C) and 
were analysed within 28 days. Samples collected and prepared at Vestfold Hospital Trust 
were kept on dry ice (-57C) for up to 24 hours, including during their transport to Oslo 
University Hospital Aker. Folate and B12 measurements were performed at Vestfold Hospital 
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Trust, vitamin B1, B2, B6, C, A and E were analysed at the Nutrition Laboratory at Oslo 
University Hospital Aker, whilst 25(OH)D was analysed at The Hormone Laboratory at Oslo 
University Hospital Aker (Paper II and III). An overview over the vitamin assays used is 
shown in Table 4.  
Serum glucose and C-reactive protein were analysed at the Department of Clinical Chemistry 
at Vestfold Hospital Trust using dry reagent slide technology on the Vitros 950 Analyser (until 
November 2006) and Vitros FS 5.1 (post November 2006) (Ortho-clinical Diagnostics, New 
York, NY; USA). Intact parathyroid hormone was essayed using an electro-
chemiluminescence immunoassay on Elecsys 2010 (Roche Diagnostics GmbH, Mannheim; 
Germany). Serum levels of insulin were measured by radio immunoassay (Insulin Coat-A-
Count, DPC, Los Angeles, CA; USA) at the Endocrine Laboratory at Oslo University Hospital 
Rikshospitalet.  
Table 4. Vitamin analyses. 
Vitamin Analyte Method Supplier 
A Retinol HPLC  Bio-Rad Laboratories 
B1 Tiamine pyrophosphate HPLC In-house method 
B2 Flavin mononucleotide HPLC Chromsystems 
B6 Pyridoxal-5’-phosphate HPLC Chromsystems 
B9 Folate Multianalyser Siemens Medical Solutions 
B12 Cobalamine Multianalyser Abbot Diagnostics 
C Ascorbic acid Micromethod Noncommercial method 
D 25-hydroxyvitamin-D RIA DiaSorin 
E -tochopherol HPLC Bio-Rad Laboratories 
HPLC: high pressure liquid chromatography 
RIA: radioimmunoassay 
 
3.6 Weight loss interventions  
3.6.1 Non-surgical intervention in the MOBIL study 
The non-surgical treatment consisted of a one year camp-based intensive lifestyle 
intervention programme which took place at Evjeklinikken, Evje, Norway. The clinic has 
developed a lifestyle programme to help morbidly obese individuals lose weight through 
dietary changes and physical activity. The lifestyle intervention programme was based on a 
cognitive approach and aimed at inducing a weight loss of 10% or more. Patients who 
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completed the one-year programme had four stays at Evjeklinikken, the first, third and fourth 
lasting for one week and the second stay lasting for four weeks (Figure 6).  
 
 
 
 
Figure 6: Overview of the stays at Evjeklinikken. 
Lifestyle intervention at Evjeklinikken included individual patient consultation with a medical 
team consisting of a doctor, dietician, physiotherapist and a nurse. In addition, all patients 
attended group sessions where the health personnel team discussed nutrition, physical 
activity and health issues related to severe obesity, including behavioural and emotional 
aspects. Three to 4 hours of organised physical activity was also included in the daily 
programme.  
No special diet, vitamin supplements or weight loss drugs were prescribed. The food served 
at the clinic followed guidelines from the Norwegian National Council of Nutrition with the 
following macronutrient composition: protein 10-20 E%, fat <30 E% (saturated fat <10 E%) 
and carbohydrate 50-60 E%. Meals were served as a buffet, with patients deciding the 
composition of their meals as well as their portions sizes.  
Patients were encouraged to practice the lifestyle interventions initiated at the clinic when 
they returned home. All patients were contacted by phone fortnightly and encouraged to self-
monitor their eating habits and physical activity by keeping a diary. Additional monthly 
consultations with a general practitioner were also recommended.  
3.6.2 Surgical intervention  
Patients opting for surgical treatment were offered individual consultations with a dietician in 
order to improve their eating habits prior to surgery. All patients attended a one day 
“operation-school” in groups of 25, where personal care, diet, supplements and the physical 
activity necessary to obtain and maintain successful long term weight-reduction were 
discussed. Relatives were welcome to attend both individual consultations and the 
“operation-school”. 
To reduce fat-mass volume in the abdominal region and liver size, the patients undergoing 
bariatric surgery completed a low calorie diet (800-900 kcal/day) for 3-6 weeks pre-operation.  
Patients chose either a low calorie diet based on crisp-bread, low-fat protein sources and 
vegetables or meal replacement shakes. Roux-en-Y gastric bypasses were performed 
1w
Evje
10w
Hom
4w
Evje
12w
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Evje
23w
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laparoscopically with a gastric pouch of 25 ml, an alimentary limb measured to median 120 
cm (range 80-200 cm) and a median biliopancreatic limb of 100 cm (range 50-170 cm) 
(Figure 4). The common channel had variable lengths. 
Patients were recommended the following supplements post-operatively: 1 daily 
multivitamin/mineral pill and vitamin-D with calcium (10 μg D3 and 500 mg Ca carbonate), 
both to be taken 2 times daily, ferrous sulphate (65 mg for men end 130 mg for women) and 
fish oil supplements (150 μg A, 10 μg D3 and 10 μg E). Additionally B12 (1 mg 
cyanocobalamin) was given intra-muscularly every 3 months. (Supplement details are 
described in Paper II). 
 
3.7 Statistics  
In all papers data are presented as mean (SD), mean (95 % CI), median (25th to 75th 
percentiles) or number (%). Within-group changes were tested with paired samples t-test or 
Wilcoxon signed rank test as appropriate. Between-group differences were analysed using 
either independent samples t-test or Mann-Whitney U-test for continuous variables or chi-
square or Fisher’s exact test for categorical variables. Between-group differences in within-
groups changes were evaluated using analysis of covariance (ANCOVA). Linear regression 
models with predefined dependent and independent covariates were used to assess the 
effect of treatment (paper I and II), while logistic regression models were used to assess 
odds ratio (OR) for vitamin D deficiency (25(OH)D <50 nmol/l). Statistical tests were 
considered significant at P<0.05. All statistical analyses were performed using SPSS 16.0 
(SPSS, Chicago, IL). 
In Paper I, the between-group differences of within-group changes in intake of food groups 
and nutrients were assessed using ANCOVA with adjustment for sex, age, baseline BMI and 
baseline values of the dependent variable.  
In Paper II, multiple linear regression was used to compare changes in vitamin 
concentrations after the two interventions (gastric bypass or lifestyle). In the regression 
models, change in vitamin concentrations was the dependent variable, whilst intervention 
groups, baseline BMI, age, gender and smoking were the independent variables. 
 In paper III, one unadjusted (gender) and three adjusted logistic regression analyses with 
predefined explanatory variables (season, age, current smoking status, vitamin D 
supplements, BMI and waist circumference) were used to assess the likelihood of vitamin D 
deficiency (dependent yes/no).  
 


46
3.8 Ethics 
3.8.1 Approvals 
Written informed consent was obtained from all participants. The Morbid Obesity Biobank 
Registry has been approved by the Regional Ethics Committee for Medical Research, 
[formerly the Southern Norway Regional Health Authority (reference number S-05175), the 
Norwegian Social Science Data Service (reference number 14029) and the Directorate for 
Health and Social Affairs (reference number 06/530)]. The Regional Ethics Committee for 
Medical Research also approved the MOBIL study. The MOBIL study is registered in the 
ClinicalTrials.gov-registry (identifier NCT00273104) and was conducted according to the 
guidelines laid down in the declaration of Helsinki. 
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4 SUMMARY OF RESULTS 
4.1 Paper I 
Dietary changes in obese patients undergoing gastric bypass or lifestyle intervention: 
a non-randomised controlled trial. 
This paper presents the changes in intake of various food groups and macronutrients in 
morbidly obese patients who underwent either laparoscopic gastric bypass (n=72) or an 
intensive lifestyle camp-based intervention program (n=54). Changes in intake of fruit, 
vegetables, whole grains and fish were assessed. Changes in the intake of total energy, fibre 
and percentage distribution of the energy yielding nutrients were also explored. Patients in 
the two intervention groups had similar dietary patterns at baseline. Percentage intake of 
total and saturated fat was higher than the recommended levels, while percentage intake of 
total carbohydrates was lower than is recommended (24). At baseline, intake of fruit and 
vegetables was in accordance with current food based dietary guidelines, while intake of 
whole grains was lower than recommended levels and intake of red meat was higher than is 
recommended. At 1-year follow up, patients in the lifestyle group had a significantly higher 
daily intake of fruit and vegetables and fibre than patients in the surgery group, whilst they 
had a lower percentage energy intake of total and saturated fat (P<0.002 for all).  
The intake of vegetables and fish reduced significantly in the surgery group, while intake of 
sugar reduced significantly in the lifestyle group. Red meat intake declined significantly within 
both intervention groups.  
After adjustment for sex, age, baseline BMI and baseline value of the dependent variable, we 
found that the patients in the lifestyle group significantly improved their dietary patterns  
compared to the surgery group by increasing their intake of vegetables, whole grains and 
fibre, and by reducing their percentage intake of saturated fat (P<0.001 for all). 
4.2 Paper II 
Vitamin status after gastric bypass and lifestyle intervention: a non-randomised 
controlled trial.  
In this paper we compared the changes in blood vitamin concentrations and vitamin intake in 
morbidly obese patients 1 year after laparoscopic gastric bypass surgery (n=27) and the start 
of an intensive lifestyle camp-based intervention program (n=23). The 50 patients included in 
this paper are the first of those who participated in the study described in Paper I. Baseline 
vitamin concentrations and dietary intakes were similar in the two intervention groups. Intake 
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of all measured vitamins was in accordance with recommended dietary intakes before 
intervention. Despite this, 37% of patients in the surgical group and 30% in the lifestyle group 
had low vitamin serum concentrations of vitamin D (25(OH)D), while 15% and 17% 
respectively had low vitamin C levels before treatment. The patients in the surgical group 
were recommended to take vitamin and mineral supplements (multivitamin, iron, calcium, 
vitamin D and vitamin B12) after surgery, whereas no supplements were prescribed to the 
patients in the lifestyle group.  
Compared to patients in the lifestyle group, gastric bypass patients significantly increased 
their concentrations of vitamin B6, folate, vitamin B12 and lipid-adjusted vitamin E 
concentrations (P <0.02 for all using multivariate linear regression analysis), while vitamin A 
concentrations decreased (P<0.01) during follow-up. There were no significant differences in 
concentration of vitamin B1, C and 25(OH)D between the intervention groups.  
A comparison of dietary intake within each treatment group showed that the gastric bypass 
patients had a significant  reduction in intake of energy, vitamin A, B1, B2, C, D, E and folic 
acid (P<0.008 for all), while patients in the lifestyle group experienced no significant change 
in vitamin intake.  
The surgically treated patients used significantly more multivitamins, vitamin D/calcium, 
vitamin B12 and fish oil supplements than the lifestyle patients at 1-year follow up (P<0.001 
for all).  
4.3 Paper III 
Impact of gender on vitamin D deficiency in morbidly obese patients: a cross-sectional 
study. 
In this paper we analysed the relationship between gender and vitamin D (25(OH)D) 
deficiency in 2026 (1336 women) morbidly obese patients seeking weight loss treatment. In 
addition we explored whether gender differences in vitamin D status could be explained by 
variations in overall and/or abdominal obesity (BMI and/or waist circumference respectively).   
Mean (SD) 25(OH)D concentrations were 50.0 (22.0) nmol/l in men and 53.6 (22.4) nmol/l in 
women (P=0.001). Additionally, the prevalence of vitamin D deficiency (25(OH)D <50 nmol/l) 
was significantly higher in male patients than in female patients 56% versus 47% (P<0.001).  
Dietary intake of vitamin D was assessed in a subgroup of 154 (112 women) patients by 
using the same FFQ as in Paper I and II. In men, the median (25-75th percentile) vitamin D 
intake tended to be higher during winter (10.7 (7.0-16.9) μg) than during summer 6.8 (4.5-
15.4) μg (P=0.08). We observed no significant seasonal differences in female patient vitamin 
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D intake (9.3 (5.5-12.5) μg) during winter versus (7.0 (4.4-10.3) μg) during summer (P=0.45). 
Both men and women had adequate median vitamin D intakes during the winter, whereas 
both genders had lower than recommended daily intakes of vitamin D than during summer 
(24). 
The unadjusted logistic regression analysis showed that obese men had significantly higher 
odds of vitamin D deficiency than women [odds ratio=1.41; (95% CI:1.17-1.70)]. When 
adjusting for possible confounders; season of blood sampling, age, current smoking and 
intake of vitamin D supplements; the association between male gender and vitamin D 
deficiency was slightly strengthened [odds ratio=1.52; (95% CI: 1.26-1.84)]. Adding BMI to 
the adjustments did not affect the odds of vitamin D deficiency, whereas further adjustment 
for waist circumference somewhat attenuated the relationship between male gender and 
vitamin D deficiency [odds ratio=1.39 (95% CI: 1.10-1.76)]. This finding suggests that 
abdominal adiposity may partly explain the observed higher frequency of vitamin D 
deficiency among men.  
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5 DISCUSSION 
The main findings of the papers included in this thesis are: 
 Morbidly obese patients who participated in a comprehensive lifestyle intervention 
program at a rehabilitation centre reported more favourable dietary changes 
compared to patients who underwent gastric bypass surgery. Patients in the lifestyle 
group had greater intakes (g/day) of fruit and vegetables, whole grains and fibre than 
patients treated with gastric bypass surgery, as well as lower intakes (E %) of total fat 
and saturated fat at 1-year follow up. 
 Morbidly obese patients who underwent gastric bypass surgery and took predefined 
vitamin and mineral supplementation had stable or increased concentrations of most 
vitamins 1 year after surgery compared with patients attending a lifestyle intervention 
programme who had no significant changes in the vitamin concentrations at 1-year 
follow up. 
 Fifty per cent of 2026 morbidly obese treatment-seeking Norwegian men and women 
suffered from vitamin D deficiency. Men had 40% higher adjusted odds of vitamin D 
deficiency than women.  
  
5.1 Methodological considerations 
5.1.1 Study designs and statistics 
Paper I 
Although randomised controlled trials provide high-quality evidence about the efficacy of 
medical interventions, the design of pragmatic (or practical) trials makes it possible to 
compare and assess the effectiveness of two interventions relevant to real-life clinical care 
(189;190). The MOBIL-study can be characterised as a non-randomised pragmatic clinical 
trial designed to compare the effectiveness of gastric bypass surgery and intensive lifestyle 
intervention including intermittent stays at a rehabilitation centre.  Non-randomised designs 
reduce the internal validity of a study and introduce elements of selection bias. Selection bias 
in this trial could include risk of treatment allocation bias given that one could hypothesise 
that those patients referred to intensive lifestyle treatment may have had greater motivation 
to change their dietary habits and/or physical activity than those referred to surgery (190).  
In our study, the participants in the lifestyle intervention group were older and less heavy 
than the surgery patients at baseline. Although differences in baseline weight and age in the 
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two intervention groups were adjusted for in the multivariate analyses used (ANCOVA), they 
might have affected our findings. One could hypothesise that the older and less heavy 
patients in the lifestyle group had both greater knowledge of and interest in behavioural and 
lifestyle changes than their younger and heavier counterparts in the surgery group, which 
again affected the outcome (dietary changes). Furthermore, we cannot exclude the 
possibility that unknown confounders (behavioural characteristics and genetic factors) or 
socioeconomic factors not included in our multivariate statistical analyses might have 
affected the results. One could, for example, speculate that individuals with less anxiety, less 
depression and greater intrinsic motivation for lifestyle change were referred to the lifestyle 
intervention group and achieved greater health promoting dietary changes.       
However, as all patients participating in this study underwent ordinary assessments before 
treatment and routine follow-up practiced in the public Norwegian health-care system, the 
results of this trial are of direct relevance to clinicians and reflect the real-life effect of two 
common treatment-options for morbidly obese individuals. There was no crossover and few 
drop-outs in both treatment-groups. The results therefore provide a valid comparison of the 
treatment options, and may be regarded generalisable and useful when developing future 
guidelines for care.       
Paper II 
The non-randomised design in this study may be a limitation as the confounding factors in 
the two intervention groups may differ somewhat.  Few participants were included in this 
study, which may increase the influence of extreme values on the results. The use of non-
parametric statistical tests may, however, reduce this disadvantage. To assess between-
group differences in the change of vitamin concentrations (dependent/effect variable) we 
used multivariate regression models with intervention group, baseline BMI, age, gender and 
smoking (yes/no) as 5 independent variables. Regression models including the baseline 
vitamin concentrations were also performed, with similar results as presented in the paper.  
The strengths of this study include the prospective design, the assessment of both vitamin 
status and dietary intake at baseline and 1-year follow-up, a control group consisting of 
obese patients seeking weight loss treatment through non-surgical methods and the high 
participant completion rate. The results of this study provide information about the 
supplement-recommendations being used in clinical practice after gastric bypass surgery.  
Paper III 
This study had a cross-sectional design, meaning that the results cannot indicate causation, 
which can be considered a limitation. However, the large number of consecutive morbidly 
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obese men (n=690) and women (n=1336) included over during a near 5 year cross-seasonal 
study ensures a representative sample of participants, and moreover an adequate power 
with which to answer our research question. Furthermore, the adjustments for confounding 
variables strongly associated with vitamin D status (gender, season of blood sampling, age, 
current smoking, use of vitamin D supplement, BMI and waist circumference) in the multiple 
logistic regressions can be considered significant strengths. As the study-population was 
mainly of Europoid origin, the results cannot be generalised to include other ethnic groups.   
5.1.2 Dietary assessment methods 
Measurements of habitual food intake often include reporting bias depending on the method 
used and the population studied. The most commonly used methods in assessing dietary 
intake are 24-hour dietary recalls, dietary history, weighed food records of varying durance 
and FFQs. The 24-hour recall method is a brief nutritional assessment tool giving information 
of the dietary intake the previous day. The method does not, however, necessarily give a 
representative picture of habitual intake and is often combined with other dietary assessment 
methods, for example FFQs. Dietary history is a detailed retrospective assessment method 
assessing habitual intake. As this method normally requires individual food coding for 
analysis purposes it is regarded time consuming and expensive. The weighed food record 
method is a prospective dietary assessment method, giving detailed information of a 
participant’s intake during 3-7 days. The method does, however, impose a significant 
respondent burden and is expensive to implement due to working and equipment costs. The 
FFQ method is designed to assess habitual diet over a reference period (3-12 months). The 
method is relatively easy to administer and imposes low respondent burden. Although 
respondent bias may be less if self-administered, more complete data is often achieved 
when the FFQ is administered by an interviewer.   
Underreporting is, unfortunately, a well known bias in studies of dietary intake, and it has 
been shown that independent of dietary assessment  obese individuals are more likely to 
underestimate or underreport their food intake than their lean counterparts (191-193). Recall-
based methods are susceptible to reporting-bias due to the inaccuracy of the memory (194). 
Social self-perception (desire of respondents to avoid embarrassment and project a 
favourable image to others) may affect the accuracy of both the type of food eaten and the 
amount (195). It has been reported that food rich in fat and/or simple carbohydrates are more 
commonly underreported than protein rich foods (191;192). This is consistent with the 
observation that obese under-reporters have a lower intake of sweets, desserts and snacks 
than obese non-under-reporters (196).  


53
However, despite the generalised under-estimation of total intake in all methods, the FFQ 
method is not associated with significant obesity-related underreporting in women (193).  
In Norway, a 180 food items FFQ has been developed and validated to cover the whole diet 
and assess dietary habits among men and women (177;197). This method has been used in 
studies to evaluate possible relations between diet and disease, as well as in the surveillance 
of dietary development at the population level (NORKOST 1, 2 and 3) (104;197;198).  
As we aimed at assessing the habitual food intake of the participants in our studies, and as 
foods and diet are culture-dependent, we chose to use the FFQ validated for use among 
Norwegian adults in the studies included in this thesis (177). Additionally, the use of this FFQ 
made it possible to compare our data with those from NORKOST and thereby assess dietary 
intake in the general Norwegian population with the severely obese individuals participating 
in our studies. 
Patients under-reporting their intake at baseline were identified using Black’s equations and 
guidelines to calculate cutoff levels for acceptable reported EI (183;184). Men and women 
with reported EI:estimated BMR <1.10 and <1.11, respectively, were classified as under-
reporters. Of the 154 morbidly obese participants (Paper III) we found that 30% of the 
women and 38% of the men had lower EI than was plausible, with no significant difference 
between genders (P=0.41). In contrast, a former nationwide dietary survey among 
Norwegian adults showed that more women than men underreported EI from a self-
administered FFQ (45% compared with 38%) (199). However, in the recent NORKOST 3, the 
proportion of men and women underreporting their EI was similar but lower than in the former 
survey, 15% and 17% respectively (104). The difference between the prevalence of under-
reporters in these two Norwegian studies may be explained by the fact that the cut-off levels  
for underreporting based on reported EI:estimated BMR were defined differently, <1.35 in the 
former trial (199) and <0.96 in the most recent one (104). Results in a study among 
Canadian adults showed that 54% of men under-reported EI compared to 35% of women, 
and moreover that under-reporting was more prevalent among individuals who were heavier, 
had a higher BMI and a lower education level (200). Under-reporting is a complex matter. It 
has been reported that individuals who are concerned with their body image, who diet 
regularly and/or aim to lose weight are likely to under-report their food intake (199). With the 
different definitions of cut-off levels to identify under-reporters in mind, the prevalence of 
under-reporting in our dietary survey may be considered to be in line with results from the 
first Norwegian trial (199). It should be noted that in the Norwegian nationwide survey the 
FFQs were self-administered, while in our study the questionnaires were performed as 
structured interviews, which may have provided a more accurate and complete filling of the 
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forms, which could explain the lower proportion of under-reporters. One could, however, 
argue that interviewing the participants could be considered a disadvantage given the 
potential for interviewer bias. The presence of the interviewer could result in an under-
reporting of foods considered unhealthy and an over-reporting of foods considered healthy. 
Both type of food consumed and amount of food consumed may potentially be misreported. 
However, we assume that this potential misreporting would not differ substantially between 
intervention groups, as both groups were aware of the importance of eating healthily. One 
may also hypothesise that the recent stay at the rehabilitation centre before the dietary 
interview at 1 year-follow up may have led participants in the lifestyle intervention group to 
report a healthier diet than that normally practiced in daily life.  
 
5.2 Intake of macro- and micronutrients  
5.2.1 Dietary intake before intervention 
Macronutrients 
Baseline energy intake and percentage distribution of energy yielding nutrients in our 
morbidly obese patients are presented in Table 5, column 5. Despite use of similar dietary 
assessment methods, mean total energy intake in our participants was approximately 200 
kcal/ day lower compared to baseline data from a recent Swedish study, in which mean (95% 
CI) reported daily energy intake was 2986 (2619-3354) kcal/day prior to gastric bypass 
surgery (201). Although a validated FFQ were used in both the Swedish study and our trial, 
they are developed to measure habitual intake in different countries and thereby not 
completely comparable. Reported energy intake from other comparable studies ranges from 
2100-2600 kcal/day (202-205). In these studies, other methods assessing dietary intake has 
been used (food diaries and dietary recall methods). Due to the diversities in dietary 
assessment methods used and differences in alimentary pattern among countries, one 
should be cautious when comparing total energy intake in these studies. Energy percentage 
distribution is, however, less susceptible to these concerns. The mean (95% CI) percentage 
energy from total fat in the recent Swedish study was 37.0 (34.2-38.8) E% and is comparable 
to the result in our trial. Similar energy percentage from fat was found in the SOS study, 
where obese women reported 37 E% from fat (206). A relatively high E% from total fat 
ranging from 36 to 43 E% has also been reported in similar studies (202;204;205). These 
results indicate that morbidly obese subjects have a higher than recommended total fat 
intake prior to intervention (<30 E%) (24). In other reports, data on intake of other energy-
yielding nutrients, carbohydrates and protein ranges from 39-46 E% for carbohydrates and 
14-19 E% for protein (202-206). These findings are in accordance with ours, with mean (SD) 
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E% from carbohydrates and protein being 45 (7) and 17 (3) respectively. In all these trials 
E% of carbohydrates was lower, while E% of protein was in accordance with current Nordic 
recommendations (24). 
 
Table 5. Weight, BMI and intake of energy-yielding macronutrients in morbidly obese 
patients and normal weight controls compared to participants in Norkost 3. 
 RDI1 Norkost 3 
(2010-2011) 
(n=1787)2 
Non-obese 
controls 
(n=30) 
Obese 
patients 
(n=154) 
 
P-
value3 
Weight (kg)  78 68 (8)4 131 (22) <0.001 
BMI (kg/m2)  25.5 22.7 (1.5) 44.4 (5.9) <0.001 
      
Energy intake (MJ) 
Energy intake (kcal) 
9.2-11.8 9.4 (3.3) 
2247 (789) 
9.8 (2.4) 
2329 (574) 
11.6 (4.5) 
2782 (1069) 
0.001 
0.001 
Protein E% 10-20 18 (4) 17 (2) 17 (3) 0.240 
Fat E% <30 34 (7) 35 (6) 38 (6) 0.053 
SFA E% <10 13 (3) 14 (2) 15 (3) 0.088 
MUFA E% 10-15 12 (3) 12 (2) 13 (2) 0.135 
PUFA E% 5-10 6 (2) 7 (2) 8 (2) 0.179 
Carbohydrate E% 55  
(50-60) 
44 (8) 46 (5) 45 (7) 0.557 
Sugar E% <10 7 (5) 6 (3) 7 (6) 0.247 
Alcohol E% <5 2 (5) 2 (1) 1 (1) 0.002 
Fiber (g) 25-35 24 (10) 28 (9) 29 (10) 0.483 
¹ Recommended daily intake (RDI). Nordic Nutrition Recommendations: NNR 2004 and Norwegian 
Recommendations for Nutrition and Physical activity (24;207).  
2 Norkost 3. A nationwide dietary survey among Norwegian men and women aged 18-70 years (104). 
3 Independent samples t-test used to compare values for obese patients and non-obese controls. 
4 Mean (SD), all such values.  
 
The current understanding of the dietary intake of morbidly obese Norwegians is limited 
when compared to our understanding of the dietary intake of normal weight persons. We 
therefore had 30 non-obese controls (20 women) take the FFQ at baseline. The controls 
were all health-care personnel working at Vestfold Hospital Trust. (Post hoc analyses). In 
Table 5, body weight and the intake of energy and percentage composition of macronutrients 
in participants of Norkost 3 (which represents the general population in Norway), obese 
patients and non-obese controls in our baseline dietary survey (Paper I and III) are 
presented.  
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Except for a significant difference in energy- and alcohol intake, there were no significant 
differences in macronutrient composition between obese patients and the non-obese 
controls.  
The morbidly obese men and women had similar intake of macronutrients, except for energy 
intake and percentage energy consumed from alcohol (significantly higher in men).  
Although we have no statistical basis by which to compare the intake of patients and the 
controls in our survey with that of Norkost 3, it seems that the obese patients in our study 
differed in terms of energy intake and energy percentage distribution compared to both the 
participants in Norkost 3 and our non-obese controls (Table 5). 
In our survey both obese and non-obese participants had a higher energy percentage 
consumed from saturated fat than is recommended. And, although not significant, the obese 
participants had an even higher intake of total- and saturated fat than the normal weight 
individuals. This is in line with the findings of a Belgian report which found that total energy 
and fat intake (kcal/day) were significantly higher in obese subjects compared to their lean 
counterparts (208). In contrast to our findings, protein intake was significantly higher in the 
obese individuals.  
Alcohol is a source of energy (29 kJ or 7.1 kcal/g) that may contribute to the development of 
obesity. However, data from a prospective cohort study where 19220 healthy, normal weight 
US women were followed for 12.9 years, shows that compared with non-drinkers, women 
who consumed a light (0.1-4.9 g alcohol/day) to moderate (5-14.9 g alcohol/day) amount of 
alcohol gained less weight and had a lower risk of becoming overweight and/or obese (209). 
Despite contradictory findings, this corresponds with a recent review which concluded that 
light-to moderate alcohol intake, especially wine intake, protects against weight gain, 
whereas consumption of spirits and higher levels of drinking is positively associated with 
weight gain (210). The normal weight controls in our study had a significantly higher alcohol 
intake than the obese patients. It should, however, be noted that the normal weight controls 
were well educated (health personnel) and that wine drinking is generally associated with a 
higher education background (college/university) in Norway (104).  
Micronutrients 
Although the data concerning nutritional deficiencies in morbidly obese individuals is limited, 
it has been shown that vitamin and mineral deficiencies are common (93;211). A high 
deficiency prevalence has been reported in the following nutrients: 25(OH)D (68%), iron 
(44%) and vitamin B1 (29%) (211). Another recent report shows a relatively high prevalence 
of deficiency of folic acid (24%) and vitamin B12 (4%) in bariatric surgery candidates (212). 
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However, in these studies they did not compare vitamin status to normal weight controls and 
reported no nutrient intake data.  
In Norway, it has been shown that low concentrations of several vitamins (B-6, C, 25(OH)D 
and lipid-adjusted vitamin E) is prevalent among morbidly obese patients seeking weight-loss 
treatment compared to normal weight controls (93). This has recently been confirmed in a 
Spanish report (205). Despite different dietary patterns and climatic conditions in southern 
Europe, similar differences between obese and normal weight individuals were observed as 
nutritional deficiencies were commonly found among obese Spaniards and were significantly 
more prevalent than in normal weight controls (205).  
However, little data on the intake of vitamins and minerals in obese subjects has been 
reported. In the Spanish trial, intakes of calcium and magnesium were below RDI (205), 
while intake of all vitamins and minerals except vitamin D was sufficient in a Swedish study 
(203). In our trial, we found that the intake of micronutrients in the morbidly obese patients 
(both men and women) was in accordance with recommendations (Table 6, column 5). As 
the prevalence of nutritional deficiencies has been found to be higher among morbidly obese 
than normal weight individuals (93;205), we found it interesting to investigate dietary intakes 
in these two groups. We therefore compared the vitamin and mineral intake of both non-
obese controls and the general Norwegian population participating in Norkost 3 with that of 
the baseline intakes of the morbidly obese individuals in our trials (Table 6).  
The morbidly obese patients had a significantly higher intake of vitamin B1, C, A, D and E 
than the non-obese controls (supplements included). The fact that the obese had a 
significantly higher energy intake than the non-obese may explain the higher intake of 
micronutrients. Despite the significantly higher energy intake in the obese, under-reporting of 
energy intake is expected. One could thus speculate that under-reporting is not associated 
with nutritious foods, but rather with energy-dense foods with low nutrient density (sweets, 
desserts and snacks) (196).  
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Table 6. Daily intake of selected vitamins in morbidly obese patients and normal weight 
controls compared to participants in Norkost 3. 
 RDI1 Norkost 3 
(2010-2011) 
(n=1787)2 
Non-obese 
controls 
(n=30) 
Obese 
patients 
(n=154)
P-value 
Vitamin B1 (mg) 1.1-1.4 1.6 (0.6)3 1.7 (0.7)4 2.0 (07)4 0.041 
Vitamin B2 (mg) 1.3-1.7 1.8 (0.8) 2.1 (0.9) 2.3 (0.9) 0.226 
Folic acid (μg) 300 254 (86) 278 (105) 313 (115) 0.110 
Vitamin C (mg) 75 108 (74) 170 (41) 208 (160) 0.010 
Vitamin A (μg) 700-900 886 (758) 1104 (351) 1562 (777) <0.001 
Vitamin D (μg) 7.5 5.8 (5.1) 7.7 (3.6) 9.5 (5.9) 0.040 
Vitamin E (mg) 8-10 11 (5) 12 (4) 16 (12) <0.001 
Calcium (mg) 800 920 (457) 1026 (285) 1134 (493) 0.106 
Iron (mg) 9-155 11 (4) 13 (5) 14 (5) 0.253 
¹ RDI from Nordic Nutrition Recommendations for women-men and Norwegian Recommendations for Nutrition 
and Physical activity (24;207). 
2 Norkost 3. A nationwide dietary survey among Norwegian men and women aged 18-70 years. Dietary   
supplements not included (104).  
3 Mean (SD), all such values. 
4 Supplements included all such values. 
5 The highest level for premenopausal women.  
 
It is important to note that the obese individuals in our study had an adequate and, in some 
cases, even higher intake of vitamins and minerals compared to the normal weight controls. 
Despite this, we found that a significant proportion of the obese patients had low levels of 
vitamin B6, vitamin C, vitamin D (25(OH)D) and lipid-adjusted vitamin E before intervention 
(Table 3, Paper II).  
Obesity is associated with elevated C-reactive protein (CRP) concentrations (93;213), and it 
has been proposed that systemic inflammation related to obesity may contribute to the low 
vitamin levels observed (93;214). Possible mechanisms explaining the association between 
inflammation and low vitamin levels may be reduced levels of transport proteins (albumin), 
alterations in vitamin distribution (lower plasma-/serum-concentrations despite stable 
intracellular levels) and/or increased antioxidant vitamin turnover (215). Systemic 
inflammation may thus contribute to the low serum vitamin concentrations frequently 
observed in severely obese individuals. 
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5.2.2 Weight loss and energy intake 
Weight-loss requires a negative energy-balance. Reduced energy intake may affect dietary 
composition and quality. In Paper I we compared changes in energy and energy percentage 
distribution of macronutrients and food groups in 126 morbidly obese patients undergoing 
either gastric bypass surgery (n=72) or intensive lifestyle intervention (n=54). Mean (SD) 
weight loss was 9.3 (13.3) kg (8%) in the lifestyle group and 39.6 (12.9) kg (29%) in the 
surgery group after 12 months of follow-up (P<0.001) (Figure 6).  
 
Figure 6. Mean (SD) weight from baseline to 12 months follow-up. 
A weight loss of  5% is commonly regarded as clinically meaningful (123;216). However, in 
severely obese individuals it has been suggested that a weight loss of 15-20% (at least 10 
kg) is required in order to obtain a sustained improvement in co-morbidity (217). In line with 
this, the 10-year data from the SOS study indicates a weight loss of 10 kg or more to be 
related to significant improvements in several cardiovascular risk factors (218).  
The energy deficit appearing during weight loss is covered by the energy preserved as fat, 
protein and glycogen in the body. The metabolisable energy densities in body fat, protein and 
glycogen are approximately 9400, 4700 and 4200 kcal/kg respectively (219). The energy 
deficit required per unit weight loss is thus higher for fat than for protein and glycogen. This 
explains why the higher the initial body fat mass, the higher the required cumulative energy 
deficit to produce the same amount of weight loss. Since women typically have more body fat 
than men of a similar BMI, this may explain why men tend to lose more weight than women 
given the same energy deficit (219). The commonly used rule of thumb that a cumulative 
energy deficit of 3500 kcal is required to lose 1 pound (=0.454 kg) ( 7700 kcal to lose 1 kg) 
of body weight is too simplistic given that it does not take into account the dynamic 
physiological adaptations which follow from reduced body weight (changes in body 
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composition, resting metabolic rate and altered energy cost of physical activity) (220). 
Advanced web-based dynamic simulation models have been developed to predict the time 
course of weight change in response to altered energy balance. Such model simulations can 
be useful in setting realistic weight-loss goals and tracking adherence to an intervention 
(220). However, although the “rule of thumb” mentioned above is too simplistic to predict 
weight-loss in general, it is deemed to match the predicted weight-loss in individuals with 
initial body fat above 30 kg (219). This rule may therefore be useful when predicting 
expected weight-loss for a given energy deficit in severely obese individuals.  
We collected no specific measures of body fat and have only a limited sense of physical 
activity levels from our data. However, a number of physical activity questions were 
incorporated into the FFQ. Time spent performing light (e.g. casual walking), moderate (e.g. 
brisk walking) and vigorous (e.g. jogging) intensity aerobic physical activities in periods 10 
minutes were recorded (49). Patients who performed 150 minutes of moderate intensity 
and/or 60 minutes per week of vigorous aerobic physical activities were considered to be 
physically active (221). Physical activity level was generally low at baseline in both 
intervention groups. Although there was a greater overall increase in the physical activity 
level of the lifestyle group, there was no significant difference between the intervention 
groups in terms of median time spent performing physical activities with moderate or 
vigorous intensity after 1 year (49).  
With these limitations in mind, the difference of 382 kcal per day in reported mean energy 
intake at 1 year between the two groups could account for a difference in weight reduction of 
approximately 18 kg (382 kcal/day x 365 days=139430 kcal : 7700 kcal/kg18.1 kg). The 
difference in mean weight loss between the groups was, however, 30.3 kg. The estimate of 
18 kg assumes a constant difference in energy-intake over a year, which is not the case. 
Although energy intake was measured only at baseline and 12 months in our study, one 
would assume that both intervention groups had a lower EI in the first few months after the 
start of the intervention, and that patients in the surgery group probably reduced EI 
substantially more than those in the lifestyle group initially after the start of the intervention. 
An energy intake of 566 kcal has been reported 3 months after gastric bypass surgery (222). 
The initial assumed very low calorie intake in the surgery group may explain the steep fall in 
the weight-loss curve in the first 4 months, as is illustrated in Figure 6. 
The 2 year data from the Louisiana Obese Subjects Study, a randomised controlled trial 
comparing intensive medical intervention and usual care in primary care practice, showed 
that a weight loss of nearly 10% was achievable in morbidly obese patients with BMI 40-60 
kg/m2 completing the intensive medical intervention (120). Intensive lifestyle intervention at 
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weight loss camps in Norway and Denmark show comparable results after 1 and 4 years 
respectively (223;224). In the Norwegian non-randomised controlled study, 1-year weight 
loss after bariatric surgery was compared to three conservative treatment options: a) a 
residential intermittent program, b) a commercial weight loss camp and c) a hospital 
outpatient programme. After 1 year, patients attending the conservative treatment options 
reduced their weight by 13.0% (a), 14.8% (b) and 5.3% (c) respectively. In the Danish study, 
the mean long-term weight loss maintenance after 2 to 4 years was only 5.3%. However, a 
total of 28% of the participants maintained a weight loss above 10% after 4 years. In 
accordance with findings in other studies, subjects with the highest initial weight loss had the 
highest weight loss maintenance (225-228). The Danish researchers found a positive 
association between initial body weight and weight loss. Subjects with the highest initial BMI 
also had the highest weight loss. They concluded that a low calorie diet and intensive 
physical activity at a weight loss camp seem to be of benefit for severely obese subjects 
(224).  
Only few studies have compared bariatric surgery and lifestyle intervention in terms of their 
effect on weight loss and obesity related co-morbidity. In addition to the non-randomised 
Norwegian study already mentioned (223), two randomised controlled trials assessing the 
effect of laparoscopic adjustable gastric banding and  lifestyle intervention in adults and 
adolescents have shown  that gastric banding is significantly more effective at reducing 
weight, giving health benefits and improving quality of life than non-surgical therapy 
(229;230). The dietary interventions were described in these trials, but no assessment of 
energy intake or dietary patterns before and/or after the intervention was given.   
5.2.3 Dietary intake after intervention 
Changes in macronutrients, micronutrients and food groups 
Our data shows that morbidly obese patients who participated in a comprehensive lifestyle 
program adopted greater favourable dietary changes than patients who underwent gastric 
bypass surgery. Patients in the lifestyle group had lower intakes (E%) of total and saturated 
fat and greater intakes (g/day) of fruit and vegetables, whole grains and fibre than patients in 
the surgery group at 1 year follow-up. It should be noted that except for the fact that women 
in or study (Paper I) had a significantly lower intake of energy compared to men 1 year after 
surgery, (1550 versus 1878 kcal/day P=0.003), there were no significant differences in the 
mean percentage energy from total- or saturated fat, protein or carbohydrates between 
genders (data not shown).  
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To the best of our knowledge, no previous studies have compared dietary changes in 
morbidly obese individuals undergoing either conventional lifestyle intervention or gastric 
bypass surgery, but some have assessed the intake of selected nutrients after bariatric 
surgery, including gastric bypass (202;203;231-233).  In Table 7a and b the dietary data from 
some of these studies are compared to those reported in Paper I and II in this thesis. 
Table 7a.  Dietary data (macronutrients) 1-8 years after gastric bypass surgery (selected 
studies). 
Study author 
 
Year published 
(Reference) 
Näslund 
et al. 
1988 
(203) 
Olbers 
et al. 
2006 
(231) 
Kruseman 
et al. 
2010 
(202) 
Le Roux 
et al. 
2011 
(232) 
Jeffreys 
et al. 
2012 
(233) 
 
Paper 
I 
 
Paper  
II 
Follow-up (year) 1 1 8 6 1 1 1 
Participants  26 
Female 
adults 
37 
Adults 
80 
Female 
adults 
9 
Adults 
9 
Adolescents 
72 
Adults 
27 
Adults 
Study design RCT1 RCT Non- 
RCT 
RCT Non- 
RCT 
Non-
RCT 
Non- 
RCT 
Dietary 
assessment 
method 
Diet. hist. 
+ 4 day 
WR2 
FFQ 4 day food 
record 
FFQ 3 day food 
record 
FFQ FFQ 
Suppl. included 3 Yes Yes No
Macronutrients  Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Median 
(25th-75thp) 
Energy (kcal) 
 
1063 
(399) 
1225 
 
1680 
(506) 
2325 
(184) 
1015 
(182) 
1650 
(435) 
1530 
(1147-1793) 
Protein E% 15 (4)  18  17 24 19 (3)  
Total fat E% 41 (7) 30.5 (5.5) 40 (8) 35 (1.9) 33 35 (6)  
   SFA      14 (3)  
   MUFA      12 (2)  
   PUFA      7 (2)  
CHO E% 42 (7) 52.0 (6.9) 42 (9)  48 44 44 (6)  
   Sugar E%      5 (4)  
   Fiber (g) 7 (3)    8 (5-12) 22 (6)  
Alcohol E%  1-2    1 (2)  
1RCT = randomised controlled trial 
2 WR= Weighed food record  
3 Open cells denote data not addressed 
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Table 7b. Dietary data (micronutrients and food groups) 1-8 years after gastric bypass 
surgery (selected studies). 
Study author 
 
Year published 
(Reference) 
Näslund 
et al. 
1988 
(203) 
Olbers 
et al. 
2006 
(231) 
Kruseman 
et al. 
2010 
(202) 
Le Roux 
et al. 
2011 
(232) 
Jeffreys 
et al. 
2012 
(233) 
 
Paper  
I 
 
Paper  
II 
Micronutrients  Mean 
(SD) 
   Mean 
(95%CI) 
Mean1 
(SD) 
Median 
(25th-75thp) 
Vit B1 (mg) 2     2.0 
(0.9) 
1.0 
(0.9-1.2) 
Vit B2 (mg)      2.5 
(1.1) 
1.2 
(1.0-1.8) 
Folic acid (μg)     581 
(116-1045) 
320 
(137) 
170 
(150-200) 
Vitamin C (mg) 32  
(27) 
    173 
(95) 
100 
(70-140) 
Vitamin A (μg) 1100 
(1100) 
    1381 
(602) 
930 
(630-1250) 
Vit D (μg) 3.1  
(1.5) 
   10.2 
(2.5-17.8) 
9.7 
(5.4) 
4.4 
(2.8-6.5) 
Vit E (mg)     11.9 
(5.3-18.6) 
16.4 
(7.4) 
6.9 
(5.4-8.4) 
Vit B12 (μg) 4.1  
(3.7) 
   168 
(0.32-335) 
  
Ca (mg) 479  
(245) 
   814 
(491-1138) 
1032 
(370) 
 
Iron (mg) 8.5  
(3.1) 
   25.4 
(13.5-37.0) 
9.6 
(7-25) 
 
Magnesium (mg) 175 ( 
61) 
    329 
(86) 
 
Zink (mg) 4.5  
(1.8) 
      
Food group  
 
       
Fruit /vegetables      441 (213) 
 
 
Whole grains      49 (16) 
 
 
Red meat      53 (31) 
 
 
Fish      56 (40) 
 
 
Dairy products      266 (228) 
 
 
1 Data on micronutrients are presented in this table but not included in Paper I 
2 Open cells denotes data not addressed  
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Table 7a and b show that data on dietary intake after gastric bypass surgery in many studies 
is sparse and mainly limited to intake of energy and macronutrients. As gastric bypass 
surgery has become the most common surgical procedure in the Nordic countries, widening 
our understanding of how this treatment method may affect the intake of food groups, 
micronutrients and macronutrient composition is of great interest both for patients, clinicians 
and scientists. If the novel findings in paper I and II are verified by others then they may well 
have significant clinical implications. Our findings indicate that dietary quality is not optimal 1 
year after gastric bypass surgery, and identifies some of the dietary improvements necessary 
to both prevent morbidity and optimise maintenance of weight loss more efficiently.  
 
The dietary assessment methods used in the studies presented in table 7a are described 
with varying accuracy. The validated FFQ used in this thesis and by others (231;232) has the 
advantage of providing information on typical food intake over a long period of time, and 
includes information on a wide range of foods. In contrast, the dietary information based on a 
3-4 day food records (202;203;233) is only valid for the days recorded. As obese individuals 
are frequent dieters, a dietary assessment method limited to a few days may be incapable of 
giving an accurate picture of habitual food intake. Food recording is a time consuming 
activity, and one which some patients experience as a burden, which in turn may result in 
drop outs. However, keeping a food records may help a patient increase their self-awareness 
of their eating habits, and may be regarded as an intervention in itself.    
   
Few reports include data on the intake of micronutrients after bariatric surgery. However, in a 
Swedish report the intake of several micronutrients was below recommended levels (203). 
These findings correspond with our results in Paper II, and confirm that supplements are 
necessary to ensure the adequate intake of micronutrients 1 year after gastric bypass 
surgery.  
 
In accordance with our findings, a number of reports indicate that macronutrient composition 
remains largely unchanged 1 year after gastric bypass surgery (202-204;231-233). It should 
be noted that no data on intake of saturated fat (or other fatty acids) is given in any of the 
studies presented in Table 7a, and comparison of fatty acid patterns with our data is 
therefore impossible.  
 
An increasing number of studies suggest that although gastric bypass surgery leads to a 
drastic reduction in the amount of food consumed initially, the caloric intake increases during 
the second postoperative year, whilst surgery does not alter the patient’s food choice or meal 
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pattern significantly, which suggests that broad dietary changes are difficult to achieve and/or 
sustain after gastric bypass surgery (155;204;234).  
Although a randomised controlled trial comparing gastric bypass and vertical-banded 
gastroplasty (235) showed avoidance of fatty food and a significantly reduction in fat 
percentage from 34.4 to 30.5% 1 year after gastric bypass (231), the percentage energy from 
fat had increased to 35% 6 years after gastric bypass in a subgroup (n=9) of these patients 
(232). The effect of gastric bypass on fat-intake has recently been investigated in an 
experimental rat study where it was found that gastric bypass operated rats decreased their 
intake of high-fat chow while intake of low-fat chow consumption increased 10 and 200 days 
after surgery compared to  sham control rats (P<0.001) (232). The authors hypothesised that 
this effect was in part due to post-ingestive effects leading to the formation of conditioned 
taste aversions after ingestions of larger amounts of fat mediated by increased GLP-1. 
However, since several studies in human beings, including ours, indicate an unaltered and 
unfavourable macronutrient distribution 1 year or longer after gastric bypass surgery, one 
could question if the reduced preference for high-fat foods identified shortly after surgery 
slowly attenuates, and moreover whether the fat aversion and/or intolerance gradually 
decreases due to a probable physical (dilatation of the gastric poach and intestine) and 
biochemical (gut peptide) adaptation.  
 
It has been demonstrated that gastric bypass surgery results in better weight reduction than 
gastroplasty 1 and 2 years after surgery (235). After 1 year, gastric bypass patients reduced 
their daily energy intake by 378 kcal more than gastroplasty patients (231), while no 
significant difference in reported  energy intake was noted 6 years after surgery (2325 versus  
2857 kcal/day respectively (P=0.11)) (232). This may indicate a possible transient fat 
aversion result in a more pronounced energy-deficit and thereby a greater weight reduction 
after gastric bypass compared to gastroplasty shortly after surgery. As previously noted, a 
greater initial weight loss is associated with improved long-term weight loss maintenance 
(122;129;130). The mechanisms leading to a lower energy intake in the first year after gastric 
bypass surgery could be a possible explanation for the greater long-term weight loss 
provided by gastric bypass than conventional treatment, gastroplasty and banding (155).  
 
Laurenius et al. recently demonstrated that gastric bypass resulted in reduced meal sizes, 
slower eating rates and increased habitual meal frequency (236). Eating fast is positively 
correlated with BMI (237). A reduced eating rate may potentially be caused by the risk of 
dumping syndrome and altered appetite-regulatory hormones (238). Eating slowly has been 
associated with a more pronounced response of the anorexigenic gut peptides PYY and 
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GLP-1 than eating fast, and may contribute to the initially significant weight loss (6 months) 
after gastric bypass surgery (239).   
 
Previous research concerning nutritional status and surgical treatment of morbid obesity has 
mainly focused on micronutrient status (vitamin- and minerals) during the period of rapid 
weight loss, while research in the context of changes in food choice and dietary pattern after 
bariatric surgery is limited. Moreover, of the few studies available the design is mainly cross-
sectional and the results are limited to comparing gastric bypass with gastroplasty or banding 
techniques. It has been reported that a decreased consumption of sweets and high-calorie 
beverages (which may cause dumping syndrome) may partially explain the lower energy 
intake and greater weight loss 2 years after gastric bypass when compared to gastroplasty 
(240). This is in line with findings from a cross-sectional study comparing gastric bypass with 
banding more than 1 year after surgery (241). As there is no data on absolute intakes 
(grams) in these reports, comparison to our data or food based dietary guidelines is not 
possible.  
 
Based on the available literature, the dietary data presented in Paper I and Paper II give 
additional information about dietary intake and changes following gastric bypass surgery 
compared to lifestyle intervention in the treatment of the morbidly obese. In summary, intake 
of micronutrients was adequate in both the lifestyle and the surgery groups at baseline. One 
year after intervention start the lifestyle patients had an adequate intake of micronutrients 
despite reduced energy intake. The bypass patients had mostly stable or increased 
micronutrient intake and vitamin concentrations due to dietary supplements (Table 8).  
In our work, we found that the macronutrient composition and food group intake in the 
lifestyle group improved in accordance with the Norwegian and Nordic recommendations 1 
year after start of intervention, while the gastric bypass patients had a less favourable 
macronutrient composition compared to the lifestyle patients (Figure 3, Paper I). Moreover, 
the change in intake of food groups moved in a less health-promoting direction in the surgery 
group compared to the lifestyle group (Figure 2, Paper I). There were no significant 
differences in macronutrient composition or food group intake between genders after 
intervention in any of the intervention groups (data not shown). 
In line with our own findings, data from several studies (202;203;231;233) indicate that 
favourable changes in macronutrient composition after bariatric surgery are difficult to 
achieve and/or sustain. Interestingly, data from the National Weight Control Registry 
(NWCR) point in the same direction. In this registry, individuals who have succeeded in 
losing large amounts of weight (approximately 56 kg) through either bariatric surgery or non-
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surgical methods and thereafter maintained their weight loss (13.6 kg) for 5.5 ±7.1 years 
have been compared (242). Both surgical and non-surgical participants report consuming a 
low-calorie diet (1460 vs. 1407 kcal/d). However, compared to the non-surgical participants, 
the surgical ones report a less healthy lifestyle marked by greater consumption of fast food 
and fat, less dietary restraint and less physical activity (242). 
Table 8. Intake of vitamins and minerals (including supplements), data one year after 
intervention start. 
 
Nutrient 
 
RDI1 
 
Total at baseline 
(n=126) 
 
Intensive Lifestyle 
Intervention 
(n=54) 
 
Gastric Bypass 
Surgery  
(n=72) 
 
P-value2 
      
Vitamin A (RE) 700 	 
900 
 
1371 (975, 1889) 1386 (975, 1653) 1282 (986, 1598) 0.034 
Vitamin D (μg) 7.5 8.2 (5.1, 12.1) 8.2 (5.1-12.3) 8.8 (6.0, 119) 0.110 
Vitamin E (mg) 8 	 
10 
 
13.1 (10.0, 18.9) 13.5 (10.2, 18.9) 16.2 (12.0,19.4) <0.001 
Vitamin B1 (mg) 1.1 
1.4  
1.9 (1.5, 2.5) 1.8 (1.6, 2.6) 2.1 (1.4, 2.1) 0.027 
Vitamin B 2 (mg) 1.3  
1.7  
2.2 (1.7, 2.9) 2.2 (1.7, 3.0) 2.4 (1.9, 3.0) 0.004 
 
Folate (mg)3 400  
300  
287 (231, 371) 
 
287 (228, 362) 312 (231, 366) 0.049 
Vitamin C (mg) 75 170 (122, 239) 169 (116, 239) 150 (117, 205) 0.693 
Calcium (mg) 800 1140 (725, 1441) 1140 (796, 1468) 991 (766, 1273) 0.945 
Iron (mg)4 9-15  
9  
13.4 (10.3, 16.8) 13.5 (10.5, 16.8) 9.6 (7.2, 24.6) 0.381 
Magnesium (mg) 280  
350  
402 (329,503) 410 (336, 532) 335 (270,372) 0.021 
1 Nordic Nutrition Recommendations, 2004 (24). 
2  Mann-Whitney U-test [Data given as median (25 and 75-percentile)] 
3 Women of reproductive age are recommended an intake of at least 400 μg/day. 
4 Recommended intake for postmenopausal women is 9 mg/day. 
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5.3 Vitamin D deficiency in morbid obesity 
Although there is growing evidence that vitamin D deficiency and obesity are related, the 
cause-effect relationship remains unclear (103).  
Both in the comparative prospective study of 53 morbidly obese patients (Paper II) and the 
cross-sectional study of 2026 morbidly obese patients (Paper III), we found a high 
prevalence of vitamin D deficiency, despite adequate dietary intake according to the current 
RDI (24). The definitions of vitamin D deficiency differ in the two papers and reflect the 
debate over this definition. At present, there is no consensus on the optimal 25(OH)D serum 
concentration. Some have suggested that a serum concentration of 25(OH)D 75 nmol/l 
indicate vitamin D sufficiency and <75 nmol/l insufficiency (109), while others define vitamin 
D deficiency to be <50 nmol/l (106). Although the considerations concerning adequate levels 
vary widely from 25-100 nmol/l (109;243), most agree that 25(OH)D concentrations <50 
nmol/l indicate vitamin D deficiency. This is partly based on findings that individuals who 
have 25(OH)D concentrations 50 nmol/l have no significant changes in their PTH-levels 
(106). 
In Paper II the definition of 25(OH)D deficiency was <37 nmol/l, which is the low reference 
value used in Norwegian laboratories, the healthcare system and in clinical practice. In Paper 
III the more accepted international definition of vitamin D deficiency of 25(OH)D <50 nmol/l  
was used. The use of these different reference levels is the main explanation for the 
difference in prevalence of vitamin D deficiency in the two papers. In Paper II, 37% of the 
surgery group and 30% of the lifestyle group was vitamin D deficient at baseline, while in the 
cross-sectional study (Paper III) 50% of patients were vitamin D deficient. In the latter report, 
the prevalence of vitamin D deficiency was significantly higher in men (56%) than in women 
(47%) (P<0.001). By using the same definition of vitamin D deficiency as in Paper II (<37 
nmol/l), the prevalence of deficiency was 24% for all patients, and was still significantly 
higher in men (28%) than women (21%) (P=0.001). As expected, we also found a high 
prevalence of secondary hyperparathyroidism in both men (37%) and women (33%) 
(P=0.054), which is in accordance with the findings of others (111).  
In general, our findings support previous reports showing a high prevalence of vitamin D 
deficiency in morbidly obese individuals (93;110-112;117;244-246). The somewhat lower 
25(OH)D levels at baseline (not significant) in the heavier surgical patients (Paper II) and the 
higher prevalence of inadequate vitamin D levels in men compared to women (Paper III) 
correspond with other findings as insufficient levels of 25(OH)D is associated with higher BMI 
and male gender (247). In Paper II, we reported that elevated PTH at baseline was more 
prevalent among patients referred to surgery (41%) compared to lifestyle intervention (17%), 
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which partly may be explained by the difference in BMI as the surgery patients had 
significantly higher BMI (46 kg/m2)  than the lifestyle patients (40 kg/m2) (P=0.003). The 
pathogenesis of hyperparathyroidism in obesity is not fully understood, and it is not 
completely explained by vitamin D insufficiency (248). However, it has been demonstrated 
that weight is a determinant of increased PTH (248), and that hyperparathyroidism in morbid 
obesity regresses with weight loss (249). A possible mechanism may be a direct effect of 
adipokines on PTH secretion, as a positive relationship between PTH and serum leptin has 
been shown in obesity (250). It has been suggested that leptin is a PTH secretagogue as 
injections of leptin in leptin-deficient ob/ob mice greatly increase PTH levels (251). 
Interestingly, the level of PTH, but not vitamin D, has been identified as an independent 
predictor of the metabolic syndrome in morbid obesity (252). One possible hypothesis is that 
PTH may be involved in the pathogenesis of hypertension (253). Whether the lowering of 
PTH has beneficial effects on metabolic syndrome or its components is, however, unclear. 
Possible cause-effect relationships between obesity and vitamin D deficiency 
Some of the most recent information about vitamin D status and obesity comes from studies 
in bariatric surgery patients (93;110;111). Both body mass index and body fat mass are 
shown to be inversely related to serum levels of 25(OH)D (115;116). Although the literature 
describing vitamin D content of fat tissue is limited, it has been suggested that low levels of 
circulating 25(OH)D in obese persons could be the result of an extensive sequestration in 
adipose tissue which reduces circulating levels (117). This notion was confirmed in a recent 
pilot study where Blum et al. measured the concentrations of vitamin D3 in the fat tissue and 
serum of obese adults. The subjects included in this study were morbidly obese men and 
women (mean BMI=50.6) who were scheduled to undergo bariatric surgery. Serum vitamin 
D3 and 25(OH)D was measured and abdominal subcutaneous fat tissue was collected at the 
time of surgery. The mean 25(OH)D concentration was 43.3 nmol/l, while mean 
concentration of vitamin D3 in serum and subcutaneous fat tissue was 7.8 nmol/l and 102.8 
nmol/kg respectively. Blum et al. concluded that the vitamin D3 concentrations of serum and 
fat tissue were positively correlated (r=0.68, P=0.003) and consistent with fat tissue as a 
storage reservoir (254). However, little is known about the quantity and location of vitamin D3 
in the human body, mainly because of the absence of total carcass data. Although results 
from pig trials have limited generalisability for humans, they permit tentative hypotheses. 
Through review and reanalysis of pig trials, Heaney et al. have summarised these as follows 
(255):   
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 There is not much vitamin D (vitamin D + 25(OH)D) in the body. A total storage of 
15000-27000 IU (375-675 μg or 970-1750 nmol), accounts for a 7-12 days reserve 
supply. 
 65% of total vitamin D in the body is present as vitamin D3 and 35% as 25(OH)D. 
 Nearly ¾ of vitamin D is stored in fat tissue(s), while 25(OH)D is distributed more 
evenly in the body, (20% in muscle, 30% in serum, 35% in fat and 15% in all other 
tissues). 
 Weight loss does not perceptibly elevate serum 25(OH)D as the amount of vitamin D 
in fat is simply too small. 
The mechanisms explaining the increase in serum levels of 25(OH)D after weight loss is 
unclear, and may include reasons other than vitamin-D release from fat tissue, although 
several studies report an increase in serum 25(OH)D after weight reduction. In a study of 
changes in 25(OH)D levels 4 and 20 weeks after a low-calorie diet-induced weight loss of 
10% in obese women, Tzotzas et al. concluded that 25(OH)D levels increased significantly  
by 34%, and that this increase was mainly  associated with improvement of insulin resistance 
(256).  In a German study, obese children who participated in a 1-year obesity intervention 
program including physical exercise, behaviour therapy and nutrition education, experienced 
normalised PTH and 25(OH)D levels after weight loss. The authors concluded that since the 
elevated PTH and decreased 25(OH)D observed  in obese children was normalised after 
weight loss, these alterations were consequences rather than causes of overweight (257). 
However, in contrast to the findings of Tzotzas et al. in adults, the German group saw no 
relationship between vitamin D and insulin sensitivity in children (257).  
In our studies we have explored vitamin D deficiency and PTH levels after bariatric surgery 
compared to lifestyle intervention. In Paper II 30% of patients in the lifestyle group and 37% 
in the surgery group had levels of serum 25(OH)D under reference value (<37 nmol/L) at 
baseline, which was reduced to 10% and 4% at 1 year follow-up. Although one must take 
into consideration that more patients in the lifestyle group used vitamin supplements after 1 
year than at baseline, the total intake of vitamin D did not significantly change (data not 
shown). It is therefore possible that the increase in serum 25(OH)D 1 year after lifestyle 
intervention in our patients may have been caused by weight reduction. This observation 
corresponds with those of Tzotza et al. (256). There is greater data on vitamin D status in 
morbid obesity in the context of bariatric surgery than there is in the context of lifestyle 
intervention. In a Scandinavian randomised controlled trial, vitamin status after two bariatric 
surgery procedures (gastric bypass and duodenal switch) was assessed (258). In 
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accordance with the results in Paper II, the gastric bypass patients increased their serum 
25(OH)D-levels after 1 year. The proportion of patients using of vitamin D/calcium 
supplements in our study (78%) were comparable with the figures reported by Aasheim et al. 
(74%) (258). In our study the intake of vitamin D3 from the diet was 4.4 μg per day while 
supplements additionally contributed with 35 μg (5 μg from the multivitamin/mineral pill, 20 
μg from Calcigran Forte and 10 μg from fish oil capsules). In the work of Aasheim et al. no 
dietary data was given, but the dosage of supplements was 25 μg vitamin D3 daily. In both 
trials the gastric bypass patients increased serum 25(OH)D-levels 1 year after surgery, which 
is probably explained by supplements and a substantial weight loss. However, in a recent 
report vitamin D status and secondary hyperparathyroidism were assessed 5 years after 
gastric bypass and duodenal switch, with the prevalence of secondary hyperparathyroidism 
high after both gastric bypass (40%) and duodenal switch (100%) (259). The prevalence of 
secondary hyperparathyroidism was high in all vitamin D categories studied (25(OH)D <50, 
50-74 and 75 nmol/l ) 5 years after surgery (both groups). Secondary hyperparathyroidism 
was inversely associated with serum ionised calcium, but not with vitamin D. Hewitt et al. 
concluded that the supplementation used (comparable to those recommended in Paper I and 
II) was insufficient to compensate for the impaired calcium absorption after surgery (259). 
They also question whether current supplementation regimens may require improvement in 
order to counteract the risk of bone disease in the long- term after surgery. In this 
assessment, it should be emphasised that studies have shown that BMI is inversely 
associated with increase in serum 25(OH)D in response to vitamin D supplementation, 
indicating a decreased response to supplementation in obese individuals (117;260). In Paper 
III we found no association between supplementation and vitamin D deficiency, possibly 
because supplements in Norway commonly only provide small amounts of vitamin D3 (5-10 
μg). 
Another hypothesis explaining how obesity contributes to vitamin D deficiency suggests that 
the synthesis of 25(OH)D in the liver is impaired in obese individuals compared to normal 
weight persons. Obesity, larger waist circumference and male gender are associated with 
non-alcoholic fatty liver disease (NAFLD) (261;262). Targher et al. have reported that serum 
25(OH)D levels were inversely associated with the severity of the liver dysfunction in biopsy-
proven NAFLD patients (263). This may indicate that liver disease leads to a reduced 
hydroxylation of vitamin D, and thereby a decrease in circulating 25(OH)D levels. NAFLD-
patients additionally had significantly higher waist circumferences than healthy controls 
matched for age, sex and BMI (263). Although we have no measures of liver fat or NAFLD in 
our patients, one may speculate that the 40% higher odds of vitamin D deficiency in men 
(Paper III) might partially be explained by the larger prevalence of visceral obesity and 
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possibly an impaired liver function among men. Alaninaminotransferase (ALAT) is 
considered an indirect measure of liver function. In our data, men (n=690) had significantly 
higher mean (SD) ALAT-levels than women (n=1335); 43 (27) vs. 30 (22) U/L (P<0.001), and 
there was a significant positive correlation between waist circumference and ALAT (n=2025), 
r=0.112, (P<0.001) (Data not presented in Paper III).  
It has been proposed that obese individuals are less exposed to sunlight due to their both 
partaking in fewer outdoor activities and their clothing habits, which therefore leaves them 
more prone to vitamin D deficiency (264). In some reports, outdoor physical activity is 
associated with vitamin D sufficiency (265;266), while others do not find that sun exposure 
explains low 25(OH) levels in obese individuals (267;268). In Paper III we found no 
association between vitamin D deficiency and physical activity. 
Whether vitamin D deficiency in obese individuals is a result of increased body clearance 
due to obesity-related inflammation mediated by visceral adiposity’s association with 
inflammation has been discussed in the recent literature (269).  
Despite extensive research in the vitamin D field, there remains a lack of understanding as to 
both the direction and the strength of any possible cause/effect relationship between low 
vitamin D status and obesity.   

5.4 Implications for treatment 
An increasing number of people undergo gastric bypass surgery. Between 2002 and 2010 
approximately 10000 people have had some form of bariatric surgery in Norway, with 
approximately 2500 Norwegians having undergone bariatric surgery in 2012 (Jøran 
Hjelmesæth, personal communication).  
Although gastric bypass surgery is more effective than lifestyle intervention in terms of weight 
reduction and alleviating obesity-related morbidities, our finding of a persistent unfavourable 
dietary pattern potentially counteracts other positive health effects. Improvement of dietary 
quality by reducing intake of total and saturated fat, increasing intake of fruit and vegetables, 
whole grain and fibre in accordance with current food based dietary guidelines may prevent 
cardiovascular disease, type-2 diabetes, several cancer forms and weight regain.  
Accordingly, a stronger focus on using counselling to promote a healthy diet in the post-
surgery phase and long-term follow-up might further improve the beneficial effects of bariatric 
surgery. Several therapeutics methods may be implemented to help patients achieve long-
term healthy dietary habits, including psycho-educational intervention programmes and 
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motivational guidance techniques which will encourage the motivation change needed to 
change lifestyle behaviour.  
Clinicians should be aware of the high prevalence of vitamin D deficiency in morbidly obese 
patients. Monitoring of vitamin D status should be undertaken routinely in the treatment of 
morbid obesity, with special attention paid to men. As the summer season in the Nordic 
countries is short and dietary sources for vitamin D are few, supplements should be 
prescribed when a deficiency is revealed.     
 
5.5 Topics for further research 
Bariatric surgery research has traditionally focused on maintaining a satisfactory 
micronutrient status during the subsequent rapid weight loss period, while trials focusing on 
long-term food choice and dietary pattern are rare. Further studies are needed in order to 
explore the effects of combined lifestyle interventions (including dietary advice), physical 
activity and behavioural modifications on dietary patterns in the follow up period after 
bariatric surgery. Randomised clinical trials in gastric bypass surgery patients comparing the 
effects of usual care treatment, intensive lifestyle and behavioural modification-programmes 
on risk factors for cardiovascular disease, type-2 diabetes (blood pressure, cholesterol, 
triglycerides, blood glucose, arterial stiffness) and weight regain are also needed.   
We evaluated the 1-year effect of a predefined supplementation regimen after gastric-bypass 
surgery. However, further prospective investigations exploring the long-term effects on 
vitamin status using current supplement regimen after bariatric surgery should be 
undertaken. In addition, it might be hypothesised that a normalisation of vitamin status before 
surgery may improve long-term vitamin status. This hypothesis may be tested in randomised 
controlled trials comparing the effect of various combinations of pre- and post-surgery 
supplementation regimens on long-term vitamin status. 
Research is also needed in order to investigate the complex factors underlying the 
association between obesity and low circulating 25(OH)D levels. Due to extensive 
differences in UV-radiation and dietary habits in different parts of the world, treatment 
advices should be site-adapted. In view of our findings, randomised controlled trials of obese 
men and women exploring the dose-response effect of vitamin D supplementation during 
different seasons in the Nordic countries might be of particular interest.  
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6 CONCLUSIONS 

Compared with lifestyle intervention, gastric bypass surgery was associated with less 
favourable dietary changes among morbidly obese patients as measured by macronutrient 
composition and food group choices at 1 year after start of intervention. Controlled clinical 
trials are needed to test the hypothesis that counselling with the aim of promoting a healthy 
diet after gastric bypass surgery is associated with long-term healthy eating habits and lower 
incidence of obesity related co-morbidities.  
One year after surgery, gastric bypass patients taking a standardised set of post-operative 
supplements had mostly stable or increased vitamin concentrations compared to baseline 
values and the corresponding changes in a control group undergoing lifestyle intervention. 
As dietary intake of several vitamins was inadequate 1 year after gastric bypass surgery, the 
supplements prescribed probably ensured satisfactory vitamin concentrations 1 year post 
surgery.   
Morbidly obese Norwegian men seeking weight loss treatment had significantly higher odds 
of vitamin D deficiency than women (adjusted odds ratio=1.39, 95% CI:1.10-1.76). Monitoring 
of 25(OH)D levels should take into account not only obesity and seasonal variations, but also 
gender. 

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Impact of gender on vitamin D deficiency in
morbidly obese patients: a cross-sectional study
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Background/Objective: Obesity is associated with vitamin D deficiency (25-hydroxyvitamin D (25(OH)D) o50nmol/l).
We aimed to examine the effect of gender on vitamin D status in severe obesity.
Subjects/Methods: Cross-sectional study of 2026 morbidly obese patients examined consecutively at a tertiary care centre
between November 2005 and June 2010. Serum 25(OH)D concentration and use of vitamin D supplements were registered in
all patients. Total vitamin D intake (mg/day) was assessed in a subgroup of 154 patients using a validated food frequency
questionnaire.
Results: The male (n¼ 690) and female (n¼1336) patients had a mean (s.d.) age of 45.0 (12.1) years and 42.2 (12.2) years
(Po0.001), body mass index (BMI) of 44.6 (6.0) kg/m2 and 44.3 (5.9) kg/m2 (P¼0.30) and waist circumference (WC) of 140
(13) cm and 127 (13) cm (Po0.001), respectively. Male patients had significantly lower mean 25(OH)D concentrations than
female patients 50.0 (22.0) nmol/l versus 53.6 (22.4) nmol/l (P¼ 0.001) and a higher rate of vitamin D deficiency (56% versus
47%; Po0.001). Obese men had significantly higher odds of vitamin D deficiency than women (odds ratio¼1.41; 95%
confidence interval: 1.17–1.70, Po0.001), also after adjustment for season, age, current smoking, intake of vitamin D
supplements, BMI and WC (odds ratio¼ 1.39; 95% confidence interval: 1.10–1.76).
Conclusions: Morbidly obese Norwegian men seeking weight loss treatment have significantly higher odds of vitamin D
deficiency than women. Monitoring of 25(OH)D concentrations in obese patients should therefore take gender into account.
European Journal of Clinical Nutrition (2012) 66, 83–90. doi:10.1038/ejcn.2011.140; published online 27 July 2011
Keywords: vitamin D (25(OH)D) deficiency; morbid obesity; gender
Introduction
Vitamin D is not only essential for calcium metabolism
and bone mineralization but may also have a role in the
maintenance of neuromuscular function and prevention of
coronary heart disease (Zittermann and Koerfer, 2008;
Giovannucci, 2009), some forms of cancer (Bertone-Johnson,
2009; Chiang and Chen, 2009) and other chronic diseases
(Holick, 2007; Peterlik and Cross, 2009). Obesity is associated
with increased risk of vitamin D deficiency. The inverse
relationship between obesity and serum vitamin D concen-
trations may have several explanations, including deposition
of vitamin D in body fat compartments, reduced release of
vitamin D into systemic circulation and low exposure to sun
light (Wortsman et al., 2000). Both subcutaneous and visceral
adiposity are associated with low vitamin D concentrations
(Cheng et al., 2010).
Morbid obesity (body mass index (BMI)X40kg/m2 or
BMIX35kg/m2 with at least one obesity related comorbidity)
is associated with a two- to threefold increased morbidity
and mortality (Must et al., 1999; Flegal et al., 2005;
Berrington de Gonzalez et al., 2010). In all, 5% of the
United States population and 2% of the Norwegian
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population can be classified as either morbidly or extremely
obese (BMIX40kg/m2; Ogden et al., 2006; Graff-Iversen et al.,
2007). Globally, extreme obesity is more prevalent among
women than men, with up to 70% of extremely obese
persons being women (Ogden et al., 2006). Women have
relatively more body fat than men and store more fat in the
gluteal–femoral region, while men typically store more fat in
the visceral (abdominal) depot (Blaak, 2001; Hofso et al.,
2009a). Some studies have found a higher prevalence of
vitamin D deficiency among men than women (Aasheim
et al., 2008; Lagunova et al., 2009). As vitamin D is a fat
soluble vitamin that may potentially be sequestrated in
adipose tissue (Wortsman et al., 2000), one could hypothe-
size that a gender difference in the prevalence of vitamin D
deficiency is related to differences in the amount of body fat
and/or its distribution. To address this hypothesis, we
analyzed the effect of gender on vitamin D status in a large
cohort of morbidly obese Norwegian patients. In addition,
we explored whether a possible gender based difference in
vitamin D status might be explained by variations in overall
(BMI) and/or abdominal (waist circumference (WC)) obesity.
Subjects and methods
Study population, design and setting
The Morbid Obesity Centre in Vestfold is a public tertiary
care centre, which serves approximately one million inhabi-
tants in southern Norway. A total of 2140 consecutive
morbidly obese patients who attended the Morbid Obesity
Centre between November 2005 and June 2010 were
considered for inclusion in this cross-sectional study. We
excluded 39 patients with BMIo35kg/m2 and 75 patients
because of missing measurements for either 25-hydroxy-
vitamin D (25(OH)D) (n¼48), BMI (n¼11) or both (n¼16).
The remaining 2026 patients were included in the analysis.
In addition, a subgroup of 154 patients (Hofso et al., 2009b)
examined between December 2005 and May 2006 was
evaluated in order to assess total vitamin D intake and
macronutrient composition. All patients gave written con-
sent before enrollment and the study was approved by the
Regional Committee for Medical Research Ethics and con-
ducted in accordance with the Declaration of Helsinki
(World Medical Association, 1997).
Variables
The main outcome variables were the prevalence of
vitamin D deficiency (serum concentration of 25(OH)D
o50nmol/l) and serum 25(OH)D concentration. Explana-
tory variables were gender, age, season of blood sampling
(winter (1 November through till 28 February) or summer
(1 March through till 31 October)), intake of vitamin D
supplements, total vitamin D intake (in a subgroup analysis,
see below), current smoking, central obesity (WC) and
overall obesity (BMI).
Physical examination
All patients were examined by a physician at their first visit
to the centre. Demographic data, medical history, smoking
habit, physical activity level and intake of vitamin D
containing supplements were recorded using standardized
forms. Weight and height were measured with patients
wearing light clothing and no shoes. Waist, hip and neck
circumferences were measured with a tape measure to the
nearest cm. Waist and hip circumference were measured
with the patient standing; at the midpoint between the
lowest rib margin and the iliac crest, and at the level of
the major trochanter, respectively.
Definitions
Patients who had a history of type 2 diabetes or a fasting
serum glucose concentration X7mmol/l were classified as
having type 2 diabetes (American Diabetes Association,
2009).
Ischemic heart disease was defined as a history of
percutaneous coronary intervention, coronary artery bypass
graft surgery or myocardial infarction.
Vitamin D deficiency was defined as serum 25(OH)D
o50nmol/l (o20ng/ml; Bischoff-Ferrari et al., 2006, Holick,
2007). Elevated C-reactive protein concentration was defined
as fasting C-reactive protein X7mg/l, which was the lowest
detection limit for the essay used.
Secondary hyperparathyroidism was diagnosed in patients
with a serum parathyroid hormone concentration46.9pmol/l
and concomitant serum calcium o2.54mmol/l (upper limits
of reference ranges).
Intake of vitamin D supplements was defined as daily
intake of supplements containingX5mg vitamin D (cod liver
oil, fish oil capsules, multivitamin supplements or pure
vitamin D supplements).
Data on physical activity was available in 1451 consecutive
patients examined from May 2007 until June 2010. Patients
were classified as physically active if they conducted
X60min of vigorous intensity aerobic physical activity per
week (Kurtze et al., 2007).
In Northern latitudes, ultraviolet B radiation varies with
season. During the winter season ultraviolet B radiation is
insufficient for vitamin D to be synthesized in the skin.
Patients were recruited from Southern Norway (58–601N),
where solar exposure and ultraviolet B radiation is low
during winter.
Laboratory analyses
Blood samples were obtained after an overnight fast. Serum
25(OH)D was measured at the Hormone Laboratory,
Oslo University Hospital by radioimmunoassay (DiaSorin,
Stillwater, MN, USA). The interassay coefficient of variation
for 25(OH)D was 14%. C-reactive protein was analyzed
using dry reagent slide technology on the Vitros 950
Analyzer until November 2006 and thereafter using Vitros
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FS 5.1 (Ortho-Clinical Diagnostics, New York, NY, USA). Intact
parathyroid hormone was essayed using an electro-chemilumi-
nescence immunoassay on the Elecsys 2010 (Roche Diagnostics
GmbH, Mannheim, Germany; Hjelmesaeth et al., 2009).
Dietary data
Vitamin D intake was estimated in a subgroup of 154
patients who participated in a clinical intervention study
(ClinicalTrials.gov:. NCT00273104; Hofso et al., 2009b) using
a validated food frequency questionnaire (Nes et al., 1992;
Solvoll et al., 1993; Andersen et al., 1996; Andersen et al.,
1999). The food frequency questionnaire is designed to
measure the habitual food intake of the adult population in
Norway and is suitable for estimating the intake of a variety
of macro- and micronutrients, including intake from dietary
supplements (Nes et al., 1992). The food frequency ques-
tionnaire was completed in structured dietary interviews
conducted by registered dieticians, with patients asked to
describe their dietary habits during the last year. Question-
naires were scanned (Teleform 10.0; Cambridge, UK) and the
daily intake of foods, energy and nutrients were calculated
using computer software (KBS 6.0; University of Oslo) based
on data from the Norwegian food composition table
(National Nutrition Council Norwegian Food Safety
Authority, 1995).
Calculations and equations
To identify individuals underreporting their energy intake
(EI), we calculated cutoff levels for acceptable reported EI
according to Blacks equations and practical guidelines
(Black, 2000a, b). Basal metabolic rate was estimated with
the Mifflin–St Jeor equations (Mifflin et al., 1990), which is
deemed to be the most reliable method for estimating basal
metabolic rate in both non-obese and obese individuals
(Frankenfield et al., 2005). We assumed a physical activity
level 1.56 for women and 1.55 for men, in accordance
with the Food and Agriculture Organization of the United
Nations (FAO)/World Health Organization/United Nations
University (UNU) 1985 values of low activity level for each
gender. Men and women with EI:basal metabolic rate o1.10
and o1.11, respectively, were classified as underreporters.
Statistical analysis
Data are given as either mean (s.d.; normally distributed
data), median (25th–75th percentile; non-normally distrib-
uted continuous data) or proportion (%) unless otherwise
stated. Differences between groups were analyzed using
independent samples t-test, Mann–Whitney U-test (contin-
uous data) or Fisher’s exact test (categorical data). Multiple
logistic regression with predefined explanatory variables was
used to assess the likelihood of insufficient vitamin D
concentration (yes/no). Hosmer–Lemeshow test was used
to assess the adequacy of the fit of the logistic regression
models.
We fitted four separate logistic regression models. In
model 1, gender was entered (women¼ reference) as the
sole explanatory variable in a univariate (unadjusted) logistic
regression analysis with insufficient vitamin D concentra-
tion (yes/no) as the dependent variable. In model 2, we
adjusted for well-known confounding factors, such as season
of blood sampling, age, current smoking (Brot et al., 1999)
and vitamin D supplement. To address the possible modify-
ing effects of overall obesity, in model 3, we further adjusted
for BMI. In model 4, a final adjustment was made for WC.
Interaction terms between gender and the other explanatory
variables were included and tested. A 5% statistical signifi-
cance level was chosen. The analyses were implemented in
SPSS 16.0 (SPSS, Chicago, IL, USA).
Results
Characteristics
The characteristics of the 2026 morbidly obese patients (66%
women) are shown in Table 1. Men were on average 2.8 years
older, 21 kg heavier and had 13 cm wider WC than women
(Po0.001 for all). The prevalence of type 2 diabetes and
coronary artery disease was higher among men than women,
whereas ethnicity, season of blood sampling, BMI and
physical activity did not differ significantly between genders.
Mean 25(OH)D concentrations were approximately 4nmol/l
lower in men than in women (P¼0.001).
Vitamin D deficiency—gender differences
Overall, about half of the patients had vitamin D deficiency.
In addition, vitamin D deficiency was more prevalent in men
than in women, 56% versus 47% (Po0.001). This gender
difference seemed to be most pronounced in the winter
season, but the difference was also statistically significant in
the summer season (Figure 1).
Gender differences in 25(OH)D concentrations according to season
Men had significantly lower 25(OH)D concentrations than
women during the winter season, mean (s.d.) 45.3 (17.8) nmol/l
versus 51.6 (22.4) nmol/l (Po0.001), whereas there was no
difference in the summer season, mean 53.0 (23.9) nmol/l
versus 54.8 (22.3) nmol/l, respectively (P¼0.21). Both men
(Po0.001) and women (P¼0.009) had higher 25(OH)D
concentrations during the summer season than the winter
season. Figure 2 shows the mean vitamin D concentrations in
men and women month by month.
Characteristics of participants in the dietary survey
A subgroup of 154 subjects (112 women) was included in
the dietary survey. Compared with the remaining 1872
patients in the full study population, fewer women in the
dietary survey group had serum 25(OH)D measurements
performed during the summer season: 49% versus 64%
(P¼0.001). There were no significant differences between
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the two study populations with respect to age, BMI, WC,
smoking habit or intake of vitamin D-containing supple-
ments (data not shown).
Macronutrient composition and gender differences
Men tended to report higher EI than women (P¼0.056), but
the percentage energy distribution of macronutrients did not
differ significantly between genders (Table 2). Except for
protein and alcohol, where men had a significantly higher
absolute intake than women, 17 g higher protein (P¼0.003)
and 1g higher (P¼0.018) alcohol intake, there were no
significant gender differences in terms of the absolute intake
of macronutrients.
Both men and women had a higher median percentage EI
from total and saturated fat, and lower median percentage
Figure 1 Gender differences in the prevalence of vitamin D
deficiency (25(OH)D o50nmol/l) according to season. Gray
columns, men; black columns, women.
Figure 2 Mean (s.d.) vitamin D concentrations in morbidly obese
men and women (y-axis) according to month of sampling (x-axis;
1 denotes January; 2, February; 3, March; 4, April and so on) Grey
filled circles, men; black filled squares, women.
Table 1 Characteristics of morbidly obese men and women
Total (n¼2026) Men (n¼690) Women (n¼1336) Pa
Age (years) 43.1 (12.2)b 45.0 (12.1) 42.2 (12.2) o0.001
Caucasian 1960 (97%)c 672 (98%) 1288 (97%) 0.660
Current smoker 535 (26%) 140 (20%) 395 (30%) o0.001
Vitamin D supplement 231 (11%) 65 (9%) 166 (12%) 0.046
Winter season (November through till February) 762 (38%) 267 (39%) 495 (37%) 0.468
Anthropometric measures
Weight (kg) 131 (22) 145 (22) 124 (18) o0.001
Height (cm) 172 (9) 180 (7) 167 (7) o0.001
BMI (kg/m2) 44.4 (5.9) 44.6 (6.0) 44.3 (5.9) 0.302
Waist (cm) 131 (14) 140 (13) 127 (13) o0.001
Hip (cm) 133 (12) 130 (12) 135 (12) o0.001
Waist-to-hip ratio 0.99 (0.1) 1.08 (0.08) 0.94 (0.08) o0.001
Physically actived 458 (32%) 165 (32%) 293 (31%) 0.723
Co-morbidity
Type 2 diabetes 499 (25%) 233 (34%) 266 (20%) o0.001
Coronary artery disease 91 (5%) 69 (10%) 22 (2%) o0.001
Biomarkers
25-hydroxyvitamin D (nmol/l) 52.4 (22.3) 50.0 (22.0) 53.6 (22.4) 0.001
Vitamin D deficiency 1019 (50%) 386 (56%) 633 (47%) o0.001
PTH (pmol/l) 6.7 (3.8) 7.1 (4.8) 6.5 (3.2) 0.003
Secondary hyperparathyroidism 691 (34%) 255 (37%) 436 (33%) 0.054
Insulin, fasting (pmol/l) 127.1 (112.6) 144.0 (99.6) 118.4 (117.9) o0.001
CRP (pg/ml) 10.7 (11) 9.3 (12.9) 11.5 (9.8) o0.001
CRPX7 (pg/ml) 1308 (65%) 378 (55%) 930 (70%) o0.001
Abbreviations: BMI, body mass index; CRP, C-reactive protein; PTH, parathyroid hormone.
aIndependent samples t-test or Fisher’s exact test where appropriate.
bData given as mean (s.d.; all such values).
cNumber (%; all such values).
dX60min of vigorous intensity aerobic physical activity/week (n¼ 1451).
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intake of carbohydrates, than recommended in the Nordic
Nutrition Recommendations: NNR 2004 (Nordic Council of
Ministers, 2004). According to the lower cutoff level for
plausible EI, 33 (30%) women and 16 (38%) men under-
reported their EIs, with no significant difference between
genders (P¼0.41). Mean (s.d.) physical activity level values
for women and men were 1.39 (0.51) and 1.35 (0.53),
respectively (P¼0.64).
Vitamin D intake
Men tended to have a higher total intake of vitamin D than
women (P¼0.073; Table 2). Median (25–75th percentile)
vitamin D intake tended to be higher during the winter in
men 10.7 (7.0–16.9) mg versus 6.8 (4.5–15.4) mg (P¼0.08),
but not in women: 9.3 (5.5–12.5) mg versus 7.0 (4.4–10.3) mg
(P¼0.45). According to the Nordic Nutrition Recommenda-
tions: NNR 2004 (Nordic Council of Ministers, 2004), both
genders had low median intakes of vitamin D during the
summer, whereas their vitamin D intakes were adequate
during the winter.
Odds of having vitamin D deficiency
In unadjusted logistic regression (model 1), obese men had
significantly higher odds of vitamin D deficiency than
women (odds ratio¼1.41; (95% confidence interval: 1.17–1.70;
Table 3). The association between male gender and vitamin
D deficiency was somewhat strengthened when adjusting for
season, age, current smoking and vitamin D supplements
(model 2). Further adjustment for BMI (model 3) did
not influence the odds of vitamin D deficiency,
whereas the addition of WC to the model slightly attenuated
the relationship between male gender and vitamin D
deficiency (odds ratio¼1.39; 95% confidence interval:
1.10–1.76). Although the difference between genders in
prevalence of vitamin D deficiency seemed more pro-
nounced during the winter than summer season, the
interaction term between gender and season was not signi-
ficant (P¼0.45). In addition, no significant interactions
were found between gender and other explanatory vari-
ables: age (P¼0.18), current smoking (P¼0.36), vitamin D
supplementation (P¼0.24), waist circumference (P¼0.95)
and BMI (P¼0.33).
Table 2 Macronutrient and vitamin D intake in morbidly obese men and women
Nutrient RDI a Total (n¼154) Men (n¼42) Women (n¼112) Pb
Energy (MJ) 9.2–11.8c 11.1 (8.5–13.9)d 11.9 (9–16.7) 10.9 (8.4–13.6) 0.056
Energy (kcal) 2647 (2043–3316) 2854 (2158–3982) 2603 (2011–3258) 0.056
Protein E% 10–20 16 (15–18) 16 (14–20) 16 (15–18) 0.897
Fat E% o30 37 (34–41) 37 (32–42) 37 (35–41) 0.609
SFA E% o10 15 (13–16) 14 (12–16) 15 (3–16) 0.370
MUFA E% 10–15 12 (11–14) 13 (11–14) 12 (11–14) 0.942
PUFA E% 5–10 7 (6–9) 7 (6–9) 7 (6–9) 0.727
Carbohydrate E% 50–60 45 (41–49) 45 (41–49) 45 (42–48) 0.897
Fibre (g) 25–35 27.3 (22–35) 30 (24–37) 26 (22–34) 0.207
Sugar E% o10 6 (3–10) 5 (2–10) 6 (3–10) 0.670
Alcohol E% o5e 0.3 (0–1) 0.4 (0.1–1) 0.2 (0–1) 0.062
Vitamin D (mg) 7.5 8.4 (5–12) 9.7 (5.3–15.8) 8.2 (4.7–11.3) 0.073
Abbreviations: E%, energy percentage; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; RDI, recommended dietary intake; SFA, saturated
fatty acids.
aNordic Nutrition Recommendations: NNR 2004 (Nordic Council of Ministers, 2004).
bDifference between men and women, Mann–Whitney U-test.
cIndividual mean energy intake depends on several variables, such as gender, age and physical activity level. For normal weight individuals (body mass index
18.5–25) and sedentary men and women aged 31–60 years, energy intake reference is 11.8MJ/day and 9.2MJ/day, respectively. Exact reference value for energy
intake is not possible to determine.
dMedian; 25 and 75th percentile in parantheses (all such values).
eo10g alcohol/day for women and o20g/day for men.
Table 3 Odds of morbidly obese patients having 25-hydoxyvitamin D deficiency
Explanatory variables Model 1 Model 2 Model 3 Model 4
OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P
Gender 1.41 (1.17–1.70) o0.001 1.52 (1.26–1.84) o0.001 1.52 (1.25–1.84) o0.001 1.39 (1.10–1.76) 0.006
Season 1.52 (1.27–1.83) o0.001 1.54 (1.27–1.85) o0.001 1.50 (1.24–1.81) o0.001
Age 0.98 (0.98–0.99) o0.001 0.99 (0.98–0.99) o0.001 0.99 (0.98–0.99) o0.001
Current smoking 1.34 (1.09–1.64) 0.005 1.45 (1.17–1.78) 0.001 1.42 (1.15–1.75) 0.001
Vitamin D supplement 0.79 (0.60–1.05) 0.110 0.82 (0.61–1.10) 0.164 0.80 (0.60–1.08) 0.142
BMI 1.07 (1.06–1.09) o0.001 1.06 (1.04–1.09) o0.001
Waist 1.01 (1.00–1.02) 0.186
Abbreviations: BMI, body mass index; CI, confidence interval; OR, odds ratios.
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Discussion
The main finding in this cross-sectional study of 2026
morbidly obese patients is that obese men had approxi-
mately 40% higher adjusted odds of vitamin D deficiency
than obese women.
It is well established that obesity is associated with vitamin
D insufficiency. Our data confirm previous reports showing a
high prevalence of vitamin D insufficiency in morbidly
obese subjects (Carlin et al., 2006; Aasheim et al., 2008;
Goldner et al., 2008; Lagunova et al., 2009). Our study has
demonstrated that men had higher odds of vitamin D
deficiency even after adjustment for the confounders season,
age, current smoking and vitamin D supplements (model 2).
The fact that further adjustment for BMI (model 3) did not
change this relationship suggests that the association
between male gender and vitamin D deficiency could not
explained by the degree of overall obesity. Conversely,
further adjustment for WC (model 4) slightly attenuated
the relationship, indicating that gender differences in
abdominal adiposity could potentially influence the asso-
ciation between male gender and vitamin D deficiency.
Consistent with this, previous studies have indicated that
vitamin D insufficiency in obese individuals is caused
by decreased bioavailability secondary to deposition of
vitamin D in body fat compartments (Wortsman et al.,
2000), especially in visceral fat stores (Cheng et al., 2010).
Seasonal variation, vitamin D intake and gender
Our results confirm those from previous Nordic studies
showing a significant drop in serum concentrations of
25(OH)D during the winter season in both genders (Vik
et al., 1980; Jorde et al., 2010). Interestingly, men had
significantly lower vitamin D concentrations than women
in the winter season, but not in the summer. A recent
Norwegian study of both lean and morbidly obese persons
also found that men had larger seasonal variation of vitamin
D concentration than women, in particular young non-
obese men (Lagunova et al., 2009). Similar findings have
been reported from New Zealand and Brazil, where middle
aged and older men had a larger reduction in 25(OH)D
during the winter season than women (Bolland et al., 2007;
Maeda et al., 2010).
In the Nordic Nutrition Recommendations: NNR 2004
(Nordic Council of Ministers, 2004), a vitamin D intake of
X7.5 mg/day is recommended. Little is known about the
dietary vitamin D intake of morbidly obese men and
women. The median vitamin D intake in our sub-popu-
lation of 8.4 mg/day was normal according to current Nordic
recommendations. A recent Spanish study also reported
adequate vitamin D intake according to regional recommen-
dations in overweight and moderately obese (BMI 24–35)
women (Rodriguez-Rodriguez et al., 2009). Previous studies
have shown that obese subjects tend to underreport EIs
(Heitmann and Lissner, 1995; Johansson et al., 1998),
especially women (Johansson et al., 1998). We estimated
that 30% of women and 38% of men underreported their EIs.
One British study found that women were more likely than
men to report avoiding high-fat foods (Wardle et al., 2004).
Despite an expected underreporting of fat, especially in
women, the total percentage fat intake was higher than
recommended (37% versus o30%) for both genders. Prob-
ably as a consequence of the high fat intake, the dietary
intake of the fat soluble vitamin D was adequate for both
genders in our study according to Nordic recommended
daily intake (Nordic Council of Ministers, 2004).
Somewhat surprisingly, no association was observed
between vitamin D deficiency and supplement intake. This
might have several explanations, including sequestration
of vitamin D in body fat compartments. The latter notion is
supported by a study showing that BMI was inversely
correlated with peak serum vitamin D2 concentrations after
a high dose of oral intake of vitamin D2 (50 000 IU, 1.25mg;
r¼0.56, P¼0.007; Wortsman et al., 2000). Our results are
therefore consistent with the hypothesis that vitamin D
supplementation in obese persons yield smaller increases in
vitamin D concentrations (Wortsman et al., 2000).
Sun exposure and physical activity
It has been speculated that the inadequate vitamin D status
associated with obesity is mediated in part by less ultraviolet
radiation from sun exposure (Harris and Dawson-Hughes,
2007). Solarium usage could be one possible explanation of
the higher 25(OH)D concentrations in women during
winter. However, morbidly obese women may find the usage
of solarium difficult because of the narrow space often
provided. Solarium usage was not registered in our study.
Physical activity has been identified as a contributor to
adequate vitamin D concentration in some (Scragg and
Camargo, 2008; Brock et al., 2010a; Brock et al., 2010b), but
not all (Barake et al., 2010; Cheng et al., 2010), reports. The
conflicting results may be explained by varying study
conditions, including differences in latitudes, age and
physical activity measurements. In our study, men and
women reported similar physical activity levels and we
found no association between low vitamin D status and
physical activity.
Study limitations
Strengths of our study include the prospective collection of
data in a large, homogenous population of morbidly obese
individuals and adjustment for possible confounders includ-
ing season of blood sampling, age, current smoking, use of
vitamin D supplements, BMI and waist circumference. Cross-
sectional studies are inherently limited in that they cannot
establish cause and effect relationships, and our results may
not necessarily be valid in non-white populations. Perform-
ing the biochemical analyses on a routine basis throughout
the study period may have limited the internal validity of
the study, as this increases the risk of drift of laboratory
assays.
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Conclusions
Morbidly obese Norwegian men had significantly higher
odds of vitamin D deficiency than obese Norwegian women.
Therefore, future guidelines for monitoring 25(OH)D con-
centrations should take into account not only obesity
and seasonal variations, but also gender. Clinicians should
be especially aware of the high prevalence of vitamin D
deficiency in morbidly obese men.
Vitamin D intake was comparable between men and
women and could therefore not explain the difference in
prevalence of vitamin D deficiency between genders.
Randomized controlled trials of obese men and women
exploring the dose–response effect of vitamin D supplemen-
tation during different seasons are highly warranted.
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